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ABSTRACT 
 
Research highlights psychosocial factors associated with adverse asthma events. This 
systematic review therefore examined whether psycho-educational interventions improve 
health and self-management outcomes in adults with severe or difficult asthma. Seventeen 
controlled studies were included. Characteristics and content of interventions varied even 
within broad types. Study quality was generally poor and several studies were small. Any 
positive effects observed from qualitative and quantitative syntheses were mainly short-term 
and, in planned subgroup analyses (involving <5 trials), effects on hospitalisations, quality of 
life and psychological morbidity in patients with severe asthma did not extend to those in 
whom multiple factors complicate management. 
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INTRODUCTION 
 
A significant minority of asthma patients have severe or poorly controlled disease resulting in 
daily symptoms, reduced quality of life, absences from work and frequent use of health 
services[1]. When persistent despite medical management according to guidelines[2] this is 
sometimes referred to as “difficult” asthma[3-5], which encompasses clinical subgroups with 
brittle, refractory or therapy-resistant disease[3-7] and is estimated to affect <10% of 
patients[1,3,5,7].  
 
The UK burden of severe, poorly controlled and difficult asthma is most evident in the 1,400 
deaths and over 70,000 hospital admissions attributable to asthma anually[1]. These 
contribute to a disproportionate share of asthma-related costs[8], with half the costs stemming 
from the 10% of patients experiencing the highest morbidity accounting and three-quarters 
resulting from uncontrolled disease[9].  
 
Various pathophysiological mechanisms are suggested to underlie severe and difficult 
asthma[3,5,6]. Increasingly, patient-related factors are also implicated[10]. Studies[11-16] 
identify adverse behavioural/psychological characteristics and social problems, as the major 
potentially modifiable factors associated with fatal and near-fatal asthma. Psychosocial 
problems also appear common amongst hospitalised patients[16,17] and those with brittle 
asthma[6]. Relationships between psychosocial factors and asthma are complex and two-way: 
symptoms and attacks impact on psychosocial well-being, whilst psychosocial factors can 
affect asthma via neuroimmunological pathways and by influencing adherence and other self-
management behaviours[10].  
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Psycho-educational programmes involving education, training in self-management and/or 
targetting psychosocial issues resulting from or impacting on asthma, are increasingly 
advocated. A Cochrane review of 36 trials[18] suggests that interactive self-management 
education improves health outcomes in general adult asthma populations. A meta-analysis of 
a broader range of psycho-educational interventions concluded that they are effective[19]. 
However, a Cochrane review of psychotherapeutic interventions for asthma identified a lack 
of good evidence[20] and a systematic review of relaxation techniques found limited 
effects[21].  
 
Patients in whom clinical and psychosocial factors complicate management, including those 
with severe or difficult asthma, tend to be excluded by design or default from studies of 
psycho-educational interventions summarised in most existing reviews[18-21]. It is thus 
unclear whether evidence is likely to be generalisable to this group. A previous review 
focussed specifically on “high risk” asthma patients discussed eight education programmes in 
adults and children[22] but failed to provide definitions of relevant patients or interventions, 
describe review methods, or formally synthesise and appraise results. A Cochrane review of 
educational interventions for adults attending the emergency room for asthma remains in 
protocol form[23], and data on broader psycho-educational interventions in a range of “at-
risk” patients have not been formally summarised. This is important, however, given 
contradictory assertions regarding whether interventions are likely to be more effective, given 
greater capacity to benefit[8,22], or less effective, given potential psychosocial barriers to 
education and behaviour change[10,17,24], in these patients. 
 
We therefore conducted a systematic review using recommended methods[25] to assess 
whether a range of psycho-educational interventions improve outcomes for adults with severe 
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or difficult asthma, and in doing so identify options for best practice and areas for further 
research. This forms part of, and updates, a broader review conducted in 2002-2003[26].  
 7
METHODS 
 
Searching 
 
Thirty-two health-related electronic data sources (including standard bibliographic indices, 
research registers, grey literature and non-English language databases), study reference lists, 
abstracts from 16 recent conferences, current contents from 81 journals and the last five years 
of past issues of three key journals (Thorax, Journal of Asthma, Patient Education and 
Counseling) were initially searched during 2002. Further detail on these and the complex 
permutations of terms and headings used to search for asthma-related educational, self-
management, psychosocial and multi-faceted interventions is provided elsewhere[26]. Update 
searches of six key bibliographic databases (Medline, Embase, Cumulative Index of Nursing 
& Allied Health Literature, PsycInfo, Web of Knowledge Science & Social Science Citation 
Indices and Applied Social Science Index & Abstracts), chosen on the basis that non-indexed, 
unpublished and foreign language literature identified from other sources did not contribute to 
the syntheses of high quality research in the initial review[26], were conducted to the end of 
2005.  
 
Study screening and selection 
 
Titles were screened to exclude obviously irrelevant papers. A second reviewer repeated 
searching and screening for one year (1999) across three primary databases to check the 
validity of screening procedures, which suggested that no relevant studies were likely to have 
been missed. 
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Abstracts from retained records (or titles where abstracts were unavailable) were assessed 
independently by two reviewers against a checklist based on definitions developed at the start 
of the review[26], to identify potentially relevant studies for which full texts were obtained 
and/or additional information sought where necessary (e.g. via author contact, Internet 
searching).  
 
Studies selected for in-depth review, following duplicate assessment of full texts and 
resolution of disagreements by a third reviewer:  
 
1. Evaluated an educational, self-management, psychological/psychosocial, or multi-faceted 
programme deemed to be a psycho-educational intervention on the basis that a major 
component of it: 
(a) involved interaction (i.e. more than just didactic transfer of information) between a 
patient (i.e. not a health professional or caregiver alone) and intervention provider; and 
(b) involved taking an educational, cognitive, behavioural and/or social approach to 
improving outcomes in asthma; and/or 
(c) addressed educational, cognitive, behavioural or social issues impacting on asthma or 
its management; and/or 
(d) addressed educational, cognitive, behavioural or social issues resulting from the 
consequences of asthma.  
2. Targetted a sample or subgroup of patients with a defined form of or one or more risk 
factors or indicators associated with severe or difficult asthma. Although potentially 
relevant, studies of asthma patients argued to be at risk on the basis of geographical 
location (e.g. living in an area of high asthma morbidity, mortality or social deprivation) 
or attendance at accident and emergency (A&E) or an emergency department (ED) on a 
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single occasion were not ultimately selected. These were deemed unlikely to have 
recruited more than a minority of relevant patients. Furthermore, the impact of educational 
interventions on the latter group is already the subject of a proposed Cochrane review[23]. 
3. Included an independent control or comparison group receiving an alternative form of 
care. 
 
For the purposes of the more focussed review reported here, selected studies also: 
 
1. Targetted a sample or subgroup of adult patients or a sample in which the majority (i.e. 
>50%) were adults. 
2. Compared the intervention to usual care or a minimal (e.g. didactic or “placebo”) 
intervention. 
3. Were published in English. 
4. Provided sufficient detail in published sources or following author contact on patients, 
intervention and outcomes to allow in-depth review. 
 
Study classification 
 
Following selection, two reviewers independently classified and reached agreement regarding 
categorisation of studies according to: 
 
1. The degree to which, on the basis of background work on definitions[26] and informed by 
emerging evidence from the review, they were judged to target severe or difficult asthma, 
graded as “likely” (a single clear risk factor/indicator or two weak risk factors/indicators 
only), or “definite” (two or more clear risk factors/indicators). 
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2. Intervention type, divided into education, self-management (i.e. including formal self-
monitoring and use of an action plan), psychosocial, or multi-faceted interventions (i.e. a 
psycho-educational intervention incorporating a non-psycho-educational component (e.g. 
medical treatment) in addition to education and self-management). 
3. Study design, comprising randomised or non-randomised controlled trials (RCTs, CCTs) 
and prospective or retrospective controlled observational studies (COSs). 
 
Data extraction 
 
Data describing general study characteristics, patients, interventions, methodological quality 
(see ‘quality assessment’), outcomes assessed, a descriptive summary and the significance of 
reported findings, and numerical outcome data where available in a suitable form (see ‘data 
synthesis’) were extracted from all available information sources, including any provided by 
authors (although it was not possible to contact authors for all missing information), tabulated 
and checked by a second reviewer. Disagreements or uncertainties were resolved via 
discussion. 
 
Data synthesis 
 
Findings for outcomes reported by four or more included studies were qualitatively 
synthesised. Where two or more trials reported adequate data about comparable outcomes, 
summary relative risk ratio (RR) statistics for binary outcomes and standardised mean 
differences (SMD) for continuous data were calculated for individual studies using Cochrane 
Revman software (version 4.2). If Forest plots with 95% confidence intervals (CIs) and 
statistical tests suggested there was not significant heterogeneity between individual study 
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estimates (p>0.05), quantitative syntheses (meta-analyses) were undertaken to calculate 
pooled effect sizes using a random effects model. Where there were sufficient data, subgroup 
or sensitivity analyses were planned to explore relative effectiveness across different patient 
groups and intervention types, and effects of the analysis model and summary statistic used.  
 
Quality assessment 
 
As recommended[25], methodological characteristics related to randomisation/selection of 
comparison group (as appropriate), outcome assessment, study sample and attrition, and 
analysis and reporting of results were assessed to explore study quality.  
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RESULTS 
 
Extent and selection of research (Figure 1) 
 
Figure 1 shows the research identified, screened and assessed for selection from initial and 
update searches. A number of studies initially considered for inclusion were excluded based 
on the stricter criteria for the current review (references available on request). Seventeen adult 
studies with control groups, published in English and for which adequate information was 
available for in-depth review were included[27-43].  
 
General study characteristics (Table 1) 
 
All but one of the included studies[33] were published since 1990, eight since 2000. Seven 
were conducted in the USA, four in the UK, three in other European countries and one each in 
Australia, Canada and New Zealand. The majority (12 studies) appeared to be led by 
secondary care organisations. Most findings are therefore likely to be reasonably 
generalisable to Western health service settings where care is guided by recent management 
guidelines. 
 
Patients (Table 1) 
 
Fourteen studies explicitly recruited adults only, of which nine had a minimum age of 18 and 
three of 16 years. Two did not specify ages but included patients attending an adult clinic[42] 
or of working age[38]. One study did not explicitly state that adults were recruited but the 
sample appeared to be adults[33], one included small numbers of children aged over 14 
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years[39] and one recruited patients aged two years and above but a majority were adults and 
it reported some adult subgroup analyses[31]. Eleven studies set an upper age limit, ranging 
from 40 to 72 years. One study recruited women only[41].  
 
Seven studies were judged to have “definitely” targetted patients with severe or difficult 
asthma. These included two studies by the same investigators[34,35] of ethnic minority 
patients with moderate-severe asthma who had multiple hospitalisations, emergency 
department attendances or an intensive care admission, and a study of primarily low income, 
ethnic minority patients, again with multiple hospitalisations or emergency attendances, 
referred to as having “difficult” asthma[36]. Four further studies[27,29,33,42] identified 
patients on the basis of a clear indicator of severe or poorly controlled asthma (e.g. diagnosis 
of severe asthma, hospitalisation, multiple emergency attendances) in combination with other 
socio-demographic (e.g. ethnic minority), behavioural (e.g. poor compliance) or clinical (e.g. 
previous hospitalisation or emergency attendances) risk factors, with most referring to 
patients as being “high risk”.  
 
Of the remaining ten studies, judged “likely” to have targetted severe or difficult asthma, four 
recruited hospitalised patients[28,37,39,43], one of which[39] included a subgroup analysis of 
patients with previous admissions, judged to be at higher risk. Three studies[30-32] targetted 
patients on the basis of a relatively weak indicator of severity/poor control (emergency 
attendance with or without hospitalisation) in combination with social deprivation or ethnic 
minority status. This was identified in two cases on the basis of geographical location 
alone[31,32] and in one on the basis of reporting a subgroup analysis from an RCT targeting a 
broader patient group which had been excluded from this review in its own right[30]. The 
remaining studies selected asthma patients with high anxiety/panic[41], taking sick leave due 
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to asthma[38], and with persistent symptoms despite adequate treatment[40]. It was not clear 
how the latter were identified.  
 
All studies were judged to provide a clear description of the target population, usually 
justified on the basis of increased risk of mortality, morbidity or service use. However, two 
studies did not make explicit reference to patients being “at risk”[33,43] and 10 specified 
criteria related to disease severity or the presence of physical, psychosocial or behavioural co-
morbidities that would have excluded some of the most at-risk patients[29,30,32,34-
37,40,41,43].  
 
Interventions (Box 1, Table 1) 
 
All studies evaluated a single psycho-educational programme of which three were classified 
as educational[28,30,31], four as self-management[27,37,39,43], three as 
psychosocial[33,40,41] and seven as multi-faceted[29,32,34-36,38,42]. Details of individual 
interventions are provided in Table 1 and an overview provided in Box 1. 
 
Comparisons (Table 1) 
 
All studies included a comparison group receiving usual care, of which 14 gave at least some 
description. In all but one old study[33], the usual care appears similar to current 
recommended management. However, referencing of guidelines as the basis for this was 
variable even in the recent studies and in five identification of inadequacies in medical care in 
light of guidelines either generally (e.g. lack of routine education), or for the particular 
patients targetted (e.g. under-use of preventive medication for ethnic minority patients), 
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provided a rationale for implementation of the intervention[34,35,37,39,43]. Three further 
studies identified inadequacies in standard care as a result of providing their 
intervention[31,41,42]. 
 
Study quality (Table 2) 
 
Randomisation/selection of controls 
 
There were thirteen trials, all RCTs, in which the unit of randomisation was the patient. Only 
six described randomisation methods[32,36,38-40,42], of which five were considered 
adequate [32,38-40,42]. Four referred to concealed allocation[29,38-40]. 
 
One study[28] described as randomised was classified as a COS since intervention patients 
comprised those admitted to the study hospital and controls those admitted to other local 
hospitals, all of whom appeared to be identified prospectively. In two other COSs[34,35] 
intervention patients were followed prospectively but a naturally occurring control group, 
comprising patients meeting criteria but treated elsewhere in the district, were identified 
retrospectively. In the final COS[33], intervention and control patients appeared to be 
identified retrospectively from the same site over a similar timeframe. 
 
Outcome assessment 
 
Six RCTs[27,30,31,39,40,43], and one COS[28] made reference to blinding those involved in 
assessing or scoring outcomes. In only five RCTs[29,30,36,39,42] and one COS[33] was 
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there clearly both a single primary outcome and endpoint. In five further RCTs and two COSs 
either a single primary outcome[38] or endpoint[27,28,31,32,34,43] was apparent. 
 
Sample and attrition 
 
Sample sizes ranged from 25[40] to 500 patients[31], with a median of 86. The largest study 
conducted some subgroup analyses of children and adults considered separately here.  
 
All but one RCT[40] was judged to have provided clear selection criteria. Only five RCTs 
reported sample size estimates[27,30,31,39,42] but several appeared to fail to meet these. The 
proportion of patients approached who agreed to participate ranged from 41%[43] to 
100%[29,36], with a median of 65%, in the 12 RCTs for which this could be ascertained. In 
three[31,42,43] of the six RCTs[30,31,38,41-43] that assessed the comparability of non-
participants, there was some evidence of differences, suggesting difficulties in recruiting 
patients truly representative of the target population. 
 
All RCTs and all but one of the COSs[28] presented data on, or reported assessment of, group 
comparability at baseline. In five RCTs[27,29,37,40,41] minor differences were judged 
unlikely to have any major impact on results but two RCTs[39,42] and two COSs[33,34] 
examined effects of various group differences using adjusted analyses.  
 
Numbers for whom follow up data were available could not be ascertained for two 
COSs[34,35]. Within other studies, follow up rates often varied for different outcomes at 
different time points. An assessment of the minimum follow up reported ranged from 
39%[40] to 100%[30,36], with a median of 75%. Only five studies[30,31,33,36,38,39] 
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reported <15% loss to follow up, sometimes considered a maximum acceptable to prevent 
attrition bias. However, in the three RCTs that reported assessment of the comparability of 
withdrawals, no clear differences were found[31,41,42].  
 
Analysis and reporting 
 
Details of analyses were reported or could be ascertained for all RCTs but only two of the 
COSs[33,35]. Six RCTs[29-32,38,42] specified that analyses, for at least some outcomes, 
were undertaken on an intention-to-treat (ITT) basis. A further two RCTs[36,37] and one 
prospective COS[34] in fact conducted what appeared to be equivalent to ITT analyses. Eight 
of the 14 RCTs[27,29,30,38-43], and three of the four COSs[33-35] were judged to have 
adequate reporting of outcome data. 
 
Outcomes and effectiveness (Tables 2, 3) 
 
Details of follow ups, categories of outcomes assessed and a descriptive summary of findings 
for individual studies are provided in Table 2.  
 
The maximum duration of follow up ranged from three months[40] to three years[38], with a 
median of 12 months (10 months for RCTs). Thirteen studies had more than one follow up, 
many including a short-term assessment of outcomes, often during an early intensive phase of 
longer interventions or soon after the end of shorter interventions, plus a medium- and/or 
long-term assessment beyond the end of any intervention. Results are summarised and 
synthesised on the basis of short-, medium- and long-term categories and, where appropriate, 
across all time points using data from the latest follow ups reported.  
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All studies reported assessment of one or more health outcomes (with at least a third reporting 
assessment of admissions, A&E attendances, symptoms, health status/quality of life and 
psychological morbidity). Nine studies reported one or more variables related to self-
management (with at least a third reporting assessment of medication use, other self-
management behaviours, and knowledge). The number of outcome categories assessed per 
study ranged from two[33] to 13[31], with a median of four, although the number for which 
comparative, numerical outcome data were actually reported and could thus be considered in 
synthesising results (Table 3), was often less.  
 
No studies reported statistically significant effects favouring control groups, and only one 
small RCT (N=27) failed to show any significant positive effects of psycho-educational 
interventions[27]. The main analyses from nine of the 13 RCTs and three of the four COSs 
showed statistically significant impacts on one or more health outcomes. Eight of the nine 
studies reporting self-management outcomes, including four that did not find any significant 
impacts on health outcomes[28,37,38,42], showed significant effects on one or more aspects 
of self-management. However, in several studies[28,29,34,36,38,42] effects were confined to 
isolated outcomes at single time points. Only two very small RCTs (N<35)[40,41] showed 
consistent statistically significant effects across all outcomes reported. 
 
Table 3 presents a summary of findings in relation to outcomes reported as assessed by at 
least four studies, thus allowing meaningful synthesis. Qualitative syntheses of individual 
study results show a lack of positive effects of psycho-educational interventions on health 
status/quality of life, psychological morbidity and time lost from work, conflicting findings 
with respect to admissions, A&E attendances and symptoms, and mainly positive effects on 
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various aspects of self-management, medication use, knowledge and respiratory function. 
However, most of the latter were assessed by small numbers of studies and any positive 
effects appear to be mainly short-term.  
 
Calculation of meaningful summary statistics and limited quantitative syntheses were able to 
be undertaken for several health outcomes for which there were a sufficient number of RCTs 
measuring and adequately reporting outcomes in similar ways. Generally, these studies were 
of higher quality than others. Using data from the latest follow ups reported, pooled estimates 
summarised in Table 3 suggest psycho-educational interventions have little effect on A&E 
attendances (RR=1.03, 0.82 to 1.29, p=0.8) or composite symptom measures (SMD=-0.08, -
0.39 to 0.23, p=0.63), and small but non-significant effects on admissions (RR=0.79, 0.55 to 
1.14, p=0.21; Figure 2), asthma-specific quality of life (SMD=0.45, -0.07 to 0.98, p=0.09; 
Figure 3) and psychological morbidity (e.g. depression) (SMD=0.17, -0.15 to 0.49, p=0.30; 
Figure 4). Effects on symptoms, quality of life and psychological morbidity appeared greater 
in the short-term (Table 3).  
 
Sensitivity analyses demonstrate that admissions and quality of life data were sensitive to the 
analysis methods used: statistically significant effects were observed (RR=0.75, 0.56 to 0.99, 
p=0.04; SMD=0.36, 0.00 to 0.72, p=0.05 respectively) when a fixed effects model was 
applied and for admissions, when odds-ratio statistics calculated (OR=0.70, 0.49 to 0.99, 
p=0.04) (Table 3). Limited subgroup analyses suggest that significant positive effects of 
psycho-educational interventions on admissions and quality of life observed across studies 
with “likely” targetting, do not extend to studies with “definite” targetting (Figures 2,3). 
Small but non-significant effects on psychological morbidity are also largely eliminated when 
analyses are confined to studies of the most at-risk patients (Figure 4). Furthermore, subgroup 
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analyses of higher risk patients in individual studies suggest a similar pattern with respect to 
symptoms[29] and time lost from work[28]. The relative effectiveness of different 
intervention types could not be examined since all meta-analyses included studies examining 
at least three different types. 
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DISCUSSION 
 
Principal findings 
 
There is a recent and growing literature on psycho-educational interventions for adults with 
severe and difficult asthma, but high quality RCTs targetting the most at-risk patients remain 
limited. Overall, qualitative and quantitative syntheses provided no clear, consistent evidence 
of the effectiveness of psycho-educational interventions on health outcomes in a range of 
adults with severe or difficult asthma. Largely positive effects on self-management-related 
outcomes, statistically significant effects on health outcomes from individual studies and 
potentially important but non-significant pooled effects on admissions, quality of life and 
psychological morbidity were mainly confined to the short-term. However, many studies were 
small and likely underpowered, and the limited numbers of studies and patients included in 
meta-analyses resulted in wide confidence intervals.  
 
Limited subgroup and sensitivity analyses suggest psycho-educational interventions may have 
important effects on admissions (leading to ~30% reduction), quality of life and possibly 
psychological morbidity in patients with severe asthma or single risk factors alone. However, 
these effects do not appear to extend to patients with multiple factors complicating 
management. Although based on small numbers of studies, the consistency of this finding 
across several outcomes where results from different studies were pooled, and observation of 
a similar failure of effects to extend to higher risk patients in two individual studies including 
subgroup analyses, point to its authenticity. This is also supported by our review of a larger 
number of studies in children[26]. Due to the limited number of studies suitable for inclusion 
in meta-analyses, range of interventions assessed and tendency for more intensive 
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interventions to target more complex patients, we were unable to explore the relative 
effectiveness of intervention types. 
 
Strengths and weaknesses 
 
This review complements and expands upon existing systematic reviews in this field which 
have suggested that some psycho-educational interventions for asthma are effective[19-22]. 
We had some success in answering questions regarding the generalisability of findings from 
these to the clinically and economically important subgroup that accounts for the majority of 
morbidity, mortality and costs associated with asthma. Unlike the only previous review 
focussed on high risk patients[23], we undertook wide and thorough searching and used 
explicit definitions and systematic methods in selecting, assessing and synthesising literature 
in an attempt to provide a comprehensive and unbiased picture of the evidence. The criteria 
we used to select studies judged to have targetted patients who, on the basis of previous 
literature[3-7,11-17], were considered to be at-risk from their asthma could be argued to be 
somewhat arbitrary. However, the criteria were rigorously applied and we were, to some 
extent, able to assess the impact of the criteria on our conclusions via our subgroup analyses 
to explore the relative effectiveness of interventions across different patient groups. 
 
In contrast to some other reviews[19,21,22], our criteria for selection of relevant interventions 
were very explicit and, because they were wide, allowed us to examine in detail the 
characteristics of a broad range of potentially related interventions, and in so doing challenge 
previous distinctions made between educational, self-management, multi-faceted and some 
psychosocial programmes. The fact that there were often greater differences across 
interventions classified as being of the same type than of different types in terms of, for 
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example, their content, delivery and intensity, can be argued to justify our synthesis of 
findings across a spectrum of psycho-educational programmes. Due to the diversity of 
interventions, range of parameters on which they varied and relatively small number of 
studies that were able to be included in meta-analyses we were not, however, able to explore 
the impact of differences in interventions on our conclusions. 
 
Having focussed on patients who are commonly excluded from existing studies, we included 
a broader range of study designs than is common in systematic reviews, on the assumption 
that well-conducted COSs might usefully supplement data from RCTs in an area where 
research is limited and challenging. However, conclusions are little influenced by the COSs 
since they made a minimal contribution to qualitative syntheses and did not contribute to 
quantitative syntheses due to limited assessment and reporting of outcomes. Even amongst the 
RCTs, the generally poor quality of studies must also be considered. For example, none 
reported on, or adequately met, all quality criteria and less than half[29,30,38-40,42] reported 
on, or adequately met, all criteria within any one of the dimensions assessed. However, poor 
reporting, apparent in the frequent failure to provide details of patient flow, baseline group 
comparability and statistical analyses, may have masked study quality.  
 
In an attempt to overcome biases, non-English language and unpublished data sources were 
originally searched but, in line with recent methodological research[44], we found that these 
ultimately contributed little to initial syntheses of higher quality research, hence their 
exclusion from the updated review reported here. However, at least two RCTs with potential 
to contribute to the findings have remained published only as abstracts since 2002 and were 
thus excluded. Furthermore, two very small published RCTs that were included reported the 
most consistently positive findings[40,41]. This may indicate the potential for publication bias 
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to have influenced our results. The summaries of results are also somewhat dominated by 
several trials reporting multiple outcomes[31,42,43] and may be influenced by selective 
reporting, apparent in numerous studies. 
 
Implications 
 
With regards to clinical practice, our results suggest that for adults with severe asthma or 
single risk factors associated with adverse outcomes, provision of psycho-educational 
interventions may improve self-management, reduce hospital admissions and improve some 
health outcomes in the short-term. There is currently a lack of evidence, however, to warrant 
significant changes in the care of patients in whom multiple clinical and psychosocial factors 
complicate management. Since several studies identified continued inadequacies in the 
medical care these patients receive, it appears that until further research is available the 
emphasis should be on optimisation of routine care to address clinical concerns and also, 
ideally, acknowledge potential complicating psychosocial factors. 
 
In terms of further research, our review highlights opportunities for additional primary and 
secondary studies to identify key risk factors for severe and difficult asthma, clarify how these 
interact with each other and over time, and develop tools to better identify patients susceptible 
to adverse outcomes to ensure appropriate targeting of any future interventions. Our review 
also suggests scope for further work on developing and evaluating psycho-educational 
interventions for at-risk groups. The apparent increasing overlap between different types of 
interventions suggest that an alternative conceptualisation of these, in light of the pathways by 
which psychosocial factors and asthma interact[10], may be a necessary precursor to this. 
Given its established effectiveness in general[18] and function as a core component of many 
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of the more effective interventions reviewed, self-management is likely to be a central feature. 
However, it is increasingly recognised that use of formal psycho-educational theories and 
techniques, which appeared to be lacking from the majority of studies reviewed, may be 
necessary to achieve self-management-related behavioural changes, particularly amongst 
complex patients[10]. For example, psychosocial consequences of living with a severe illness 
or recurrent exacerbations (e.g. depression, anxiety), may need to be addressed and patients’ 
coping improved prior to attempts at behavioural change[10]. Given the need for provision of 
optimal medical care alongside any psycho-educational interventions, multi-faceted, multi-
disciplinary programmes addressing the numerous factors impacting on asthma, may be the 
most promising future approach. These might target key issues (e.g. stress management) in 
selected patients (e.g. those with high anxiety) or address multiple issues and be 
individualised to needs amongst broader groups of complex patients. Given identified 
difficulties with at-risk patients attending healthcare facilities, interventions tied to 
opportunistic contacts in emergency, primary care or community settings may also be 
desirable. The development of future interventions might also usefully be guided by reference 
to the wider range of programmes identified in our original review which have not been 
evaluated via controlled studies[26]. 
 
Although several studies reviewed mentioned difficulties in conducting high quality research 
in the groups targetted, most demonstrated some success in recruiting and following up at-risk 
patients. It thus appears feasible to conduct further well-designed, pragmatic RCTs of psycho-
educational interventions in at-risk groups to assess their relative effectiveness, and ideally 
cost-effectiveness given potentially high costs and lack of current data on this[26]. These 
might address remaining unanswered questions regarding the key components, most effective 
settings, delivery methods and timing of interventions (e.g. whether scheduled to follow acute 
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events). Adequate reporting of these is also essential to allow ongoing evidence syntheses to 
further inform future research and practice. 
 
Conclusion 
 
There is some evidence to suggest that psycho-educational interventions can reduce 
admissions, improve quality of life and possibly reduce psychological morbidity in patients 
with severe asthma or single characteristics associated with difficult asthma. However, effects 
appear to be mainly short-term and do not appear to extend to the most at-risk patients in 
whom multiple factors complicate management. There is thus a need for further research in 
these groups prior to changes being made to the standard care these patients receive. 
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Box 1 Overview of intervention characteristics 
Setting 
 
All but two studies, both of psychosocial interventions[33] [41], indicated the setting for 
intervention delivery. Seven, including all but one self-management intervention, were 
delivered at least partly in an inpatient setting[27][28][29] [32] [37][38][39], four solely on an 
outpatient basis[35][36] [40] [43], two in the emergency department[30] [34] and two in 
community or home environments[31] [42].  
 
Providers 
 
Twelve studies involved nurses and five doctors, all but one of which evaluated a multi-
faceted intervention incorporating additional medical treatment. One educational[31], one 
psychosocial[33], and four multi-faceted interventions[35] [36] [38] [42] involved additional 
professionals (e.g. psychologists, community health workers, pharmacists, physiotherapists, 
dieticians). In three studies[34] [40] [43] the providers’ professions were unclear. Eleven 
studies reported on the number of providers[27] [29][30][31] [33] [36][37] [39][40][41][42], 
ranging from one to four. Six referred to specific training undertaken by, or supervision given 
to, providers[28] [30][31] [33] [39] [42]. Four studies included details of providers’ 
experience, gender or shared ethnic, linguistic or cultural background with patients[31] [33] 
[41][42].  
 
Format, structure and timing 
 
All but one study[38] provided information on the delivery format. In 12, delivery was on an 
individual basis, two delivered interventions to medium-sized groups[30] [43], one to a small 
group [41], and one to a group of unspecified size[33]. Only seven studies provided complete 
information on the number, duration and frequency of intervention contacts and total 
intervention duration[31] [34] [36][37] [41][42][43]. Across all studies where one or more of 
these dimensions was reported, they often varied according to patient needs, time available 
for contact (e.g. during an admission) or at different stages of the intervention, but where 
specific figures could be ascertained: 
 
• the number of sessions varied from one, for a self-management intervention[43], to 12, for 
a psychosocial intervention[41]; 
• individual session duration varied from a minimum of 30 minutes, for one educational[28] 
and two self-management interventions[37] [39], to up to three hours, for a self-
management intervention[43], with sessions most commonly lasting around an hour; 
• the frequency of contacts ranged from daily, in one self-management programme[37], to 
initial contacts at monthly intervals in a multi-faceted intervention[35]; 
• the intervention duration ranged from the time taken to deliver a single session in one self-
management programme[43] to several years in a psychosocial intervention[33]; and 
• total contact time ranged from a minimum of 30 minutes during a single educational 
session[28] to nine hours for a psychosocial intervention[41]. 
• judgements about the overall intensity of the intervention could only be made for a small 
number of studies, but appeared greatest for psychosocial and multi-faceted interventions. 
 
Eleven interventions, including all the educational and self-management programmes and half 
the multi-faceted programmes, followed an asthma episode (e.g. hospitaliation, emergency 
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attendance, recent attack)[27][28][29][30][31][32] [34] [36][37] [39] [43] but the exact timing 
of the start of the intervention from the episode was not always clear.  
 
Delivery methods/tools 
 
All interventions appeared to use formal or informal discussion and/or questioning in groups 
or individually, commonly covering experiences with, and problems related to, asthma 
management. All but one study of a psychosocial intervention[33] incorporated skills training, 
including demonstration of correct use of inhalers, related equipment and peak flow meters, 
and training in self-management procedures, relaxation or other psychotherapeutic techniques, 
trigger management or social skills. Fourteen studies supplemented face-to-face delivery with 
written information and seven with telephone contact. Seven interventions included a didactic 
component. All three psychosocial interventions made use of formal psychotherapeutic 
techniques, two cognitive-behavioural principles[40][41], in delivery. One educational[30] 
and one multi-faceted intervention[42] also used basic relaxation techniques and cognitive-
behavioural principles respectively. Single studies used other delivery methods or tools (e.g. 
problem-solving, goal-setting, role play, video and audio technology). 
 
There were no clear patterns or differences across intervention types in terms of the delivery 
methods or tools used except that all psychosocial interventions made use of formal 
psychotherapeutic techniques. The median number of delivery methods used was estimated at 
four, ranging from three in educational to 4.5 in self-management interventions. 
 
Content 
 
Information on content was particularly sparse for one psychosocial intervention[33]. All 
interventions appeared to cover asthma medication, and all but one[33] the development of a 
general understanding of asthma (e.g. its nature, pathophysiology, causes) and aspects of 
asthma management, most commonly principles of self-management, attack management, and 
use of a peak flow meter or action plan. Fourteen discussed triggers or trigger avoidance, and 
seven regular clinic attendance. The median number of asthma-specific topics covered was 
estimated at 10. Multi-faceted and self-management interventions tended to cover a greater 
range than educational interventions, and these more than psychosocial interventions. After 
examining their detailed content, the distinction between educational and self-management 
programmes appears questionable, since two studies classified as educational interventions 
included use of formal self-management plans for at least some patients[28] [31]. 
 
All but three interventions[28] [36] [39] reported consideration of broader issues indirectly 
related to asthma and its management. Ten covered psychological issues (e.g. stress, anxiety, 
fears) and nine social or family issues. Five studies or less covered attitudes and beliefs in 
relation to asthma and its management, smoking and other health-related behaviours (e.g. 
exercise, diet) and economic problems. Other issues (e.g. communication with providers, 
occupational concerns) were addressed by single studies. The median number of broader 
issues covered was estimated at two. There was little difference in the number or categories of 
issues addressed across interventions of different types except that psychosocial interventions 
were most likely to cover psychological issues. 
 
Add-ons 
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Interventions classified as multi-faceted included non-psycho-educational add-ons, all 
incorporating enhanced medical care (e.g. optimisation of drug therapy, altered inpatient and 
follow up treatment, liaison with medical services), two individualised exercise 
programmes[38] [42], and two referral to other health, psychological or social services[32] 
[42]. Two educational interventions [30][31] involved referral. 
 
 37
Figure 1 Literature identified, screened, selected and reviewed in depth 
 Initial 2002 search and review 2005 update search and review 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Comprised 4 trials of various psychotherapeutic interventions. 
+This retrospective observational study compared patients who had undergone psychosomatic treatment to those who had discontinued treatment, and had not contributed to the 
syntheses of results in the original review.  
†These 3 studies, which included two UK-based RCTs of cognitive-behavioural therapy and a specialist nurse intervention, remained published as abstracts only at the end of 2005 
and further information was unavailable or could not be obtained from authors. 
‡This retrospective observational study comparing Medicaid patients participating in a US disease management programme to patients who had not participated, provided 
insufficient information on the intervention in a published paper to allow in-depth review and the study author did not respond to requests for further information. 
>23,000 citations identified from across 32 electronic 
databases and other sources 
4,240 citations retained and assessed for eligibility 
after initial screening and removal of duplicates 
278 citations associated with 188 studies initially 
included 
114 published and unpublished English and non-
English language documents associated with 57 
controlled studies selected for in-depth review 
9 RCTs included in one or more meta-analysis 
17 studies included in current review 
7403 citations identified from across 6 electronic 
databases 
456 additional citations assessed for eligibility after 
initial screening and removal of duplicates 
20 published English language documents associated 
with 18 studies initially selected as per original review 
criteria 
22 studies in adults/primarily adults included in initial 
review 
7 studies subsequently excluded from current review:  
• 3 no comparison to usual/non-psycho-educational 
care* 
• 1 published in Japanese only+ 
• 3 remained published as abstracts only† 
Additional papers for 3 studies in adults previously 
identified [29] [41][42] and 4 new adult studies initially 
included 
2 studies excluded after full text assessment: 
• 1 no comparison to usual/non-psycho-
educational care* 
• 1 provided insufficient information in 
published paper to allow in-depth review‡ 
35 studies in children/primarily children excluded 11 studies in children/primarily children excluded 
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Table 1 General study characteristics and details of patients, interventions and control groups 
 
Study Country & 
setting 
Targetting of severe/difficult asthma and 
sample selection 
Intervention Control group(s) 
Blixen et 
al 
2001[27] 
USA 
Tertiary care 
Targetting: Definite 
Inclusion criteria: African-Americans aged 
18-50 years hospitalised overnight with a 
primary diagnosis of asthma.  
Exclusions: None stated. 
Rationale for targetting: Asthma death rates 
among African-Americans more than double 
that in Caucasians, hospitalisation rates also 
higher amongst inner-city, low-income 
African-Americans. Group studied 
representative of those with severe asthma who 
are at risk. 
Type: Self-management 
Description: Asthma education programme including self-management 
Setting: Inpatient  
Provider(s): 1 Nurse Educator 
Format: Individual 
Structure: 3 x 1-hour sessions (frequency and total intervention duration 
not stated) 
Timing: Following admission 
Delivery methods/tools*: L, D, S, W, V (Total 5) 
Asthma content†: 10  topics related to asthma in general, management, 
medication, triggers 
Other content: Other psychological issues (dealing with stresses common 
to many African-Americans), social or family issues, other (communication 
with medical providers, contacts for local support organisations) 
Add-ons: None 
Usual care (no 
description given) 
Brewin & 
Hughes 
1995[28] 
UK 
Secondary 
care 
Targetting: Likely 
Inclusion criteria: Adults aged 16+ years  
hospitalised with asthma. 
Exclusions: None stated. 
Rationale for targetting: Patients hospitalised 
with asthma need opportunity to learn more 
about asthma so they can be independent and 
as symptom-free as possible. 
Type: Educational 
Description: Patient education with some elements of self-management 
Setting: Inpatient 
Provider(s): Respiratory Nurse  
Format: Individual 
Structure: 1+ sessions, with more shorter sessions as needed. Most seen 
for >30 mins (frequency of sessions and total intervention duration not 
stated) 
Timing: Immediately following hospital admission 
Delivery methods/tools*: D, S, W (Total 3) 
Asthma content†: 7 topics related to asthma in general, management, 
medication, triggers 
Other content: None stated 
Add-ons: None 
Usual care comprising 
all other patients 
admitted with asthma to 
hospitals in the district, 
a survey of whom 
suggested they received 
minimal education. 
Castro et 
al 
2003[29] 
USA 
Secondary 
care 
Targetting: Definite 
Inclusion criteria: Adults aged 18-65 years 
hospitalised for asthma with a physician 
diagnosis of asthma of at least 12 months, 
FEV1 to FVC ratio of <80% and a history of 
one or more additional hospitalisations or ED 
Type: Multi-faceted 
Description: Multi-faceted approach to asthma care including education, 
self-management, psychosocial support, optimization of medications and 
feedback to physicians 
Setting: Inpatient  
Provider(s): 3 Asthma Nurse Specialists 
Usual care comprising 
normal care provided 
by the patient’s primary 
care physician, and 
including asthma 
education (covering 
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Study Country & 
setting 
Targetting of severe/difficult asthma and 
sample selection 
Intervention Control group(s) 
visits in the previous 12 months.  
Exclusions: Chronic bronchitis, emphysema, 
congestive heart failure, a terminal condition 
with estimated survival of <1 year, dementia or 
serious psychiatric illness (e.g. schizophrenia, 
personality disorder), planned discharge to 
long-term care facility, early discharge of <24 
hours, refusal to participate by patient or their 
physician. 
Rationale for targetting: Hospitalisations 
account for half of healthcare expenditure for 
asthma, with African-Americans more than 
three times as likely to be hospitalised. The 
20% of the population who have a history of 
frequent healthcare use consume more than 
80% of resources. Sample targetted defined as 
“high risk”. 
Format: Individual 
Structure: As many sessions as possible before discharge (average of 2, 
duration not stated) plus follow up phone calls (average of 5.8, range 0-24) 
and home visits where necessary (average of 0.4, range 0-3) up to 6 months  
Timing: Immediately following admission 
Delivery methods/tools*: D, S, T, W (Total 4) 
Asthma content†: 10 topics related to asthma in general, management, 
medication, triggers, clinic attendance 
Other content: Other psychological issues (referral to psychiatric nurse 
where indicated), Social or family issues (social support, referral to social 
worker or consultation with social services where indicated) 
Add-ons: Medical treatment (optimisation of medical care) 
medication dosing, 
action and side effects, 
inhaler technique and 
peak flow monitoring) 
from the hospital 
respiratory therapist and 
nurse and written 
discharge instructions 
from the hospital nurse 
which stated 
medications and the 
need for physician 
follow-up but did not 
include an action or 
self-management plan. 
Ford et al 
1997[30] 
USA 
Secondary 
care 
Targetting: Likely 
Inclusion criteria: African-American 
subgroup (72% of original sample) aged 18-70 
years seen in emergency department for 
asthma.  
Exclusions: Language barriers; psychiatric 
barriers. 
Rationale for targetting: Re-analysed data 
from African-American subgroup in previous 
study since asthma death rates twice as high 
among African-Americans (acounting for 86% 
of deaths in one study) and, morbidity and 
treatment costs also disproportionately high. 
Type: Educational 
Description: Educational intervention including basic relaxation training 
Setting: A&E 
Provider(s): 2 Nurses 
Format: Medium group (5-15 people) 
Structure: 3 x 1-hour sessions (frequency and total intervention duration 
not stated) 
Timing: During A&E visit for exacerbation 
Delivery methods/tools*: D, S, P, FT, W, A (Total 6) 
Asthma content†: 8 topics related to asthma in general, management, 
medication, triggers 
Other content: Smoking, other health-related behaviours, attitudes/beliefs 
(beliefs in self-care), other psychological issues (stress management), social 
or family issues, other (physician communication, other medication) 
Add-ons: Referral (to stop-smoking programmes as required) 
Usual care comprising 
admission to and 
discharge from A&E 
with usual care and 
follow up 
Garrett et 
al 
1994[31] 
New Zealand 
Community 
Targetting: Likely 
Inclusion criteria: Patients aged 2-55 years 
(majority adult and including adult subgroup) 
with acute asthma diagnosed by a doctor whilst 
attending the emergency room who lived 
within a defined geographical area with high 
A&E use and social depriviation and intended 
Type: Educational 
Description: Community health care intervention comprising education, 
link to GP/referral 
Setting: Home, Community, Other (workplace or as according to patients’ 
wishes) 
Provider(s): 4 Nurses & Community health workers 
Format: Individual 
Usual care comprising 
usual management by 
physicians with referral 
to hospital asthma 
clinic for some patients 
 40
Study Country & 
setting 
Targetting of severe/difficult asthma and 
sample selection 
Intervention Control group(s) 
to reside locally for next 9 months; understood 
English sufficiently and; could be contacted 
within 5 days of attending. 
Exclusions: None stated. 
Rationale for targetting: Mortality and 
admission rates for asthma in Auckland are 
highest amongst patients attending A&E from 
within the geographical area of high social and 
medical needs targetted. This area also has a 
large immigrant population and rates are up to 
four times higher in Pacific Islander, ethnic 
minority and Maori patients due to lack of self 
management skills, social factors and non-
attendance. 
Structure: Number of sessions as needed (mean 3.7, range 1-10) with 
duration of sessions dependent on educational needs of patient, and 
intervention continued until all topics covered 
Timing: Following recent attack 
Delivery methods/tools*: D, S, W (Total 3) 
Asthma content†: 11 topics related to asthma in general, management, 
medication, triggers, clinic attendance 
Other content: Smoking, attitudes/beliefs, social or family issues, 
economic issues (assessment of social, financial & cultural beliefs) 
Add-ons: Referral (links with GPs and contact with other health, mental 
health or social service agencies or support structures as appropriate) 
George et 
al 
1999[32] 
USA 
Secondary 
care 
Targetting: Likely 
Inclusion criteria: Adults aged 18-45 years 
living in area around hospital which 
predominantly populated by African-
Americans who were hospitalised from ED 
with (uncomplicated) acute exacerbation of 
asthma. 
Exclusions: Patients admitted to intensive 
care; inability to speak English; comorbid 
disease; absence of telephone; pregnancy. 
Rationale for targetting: Disproportionate 
morbidity and mortality in poor, indigent, 
inner-city patients due to allergens, smoking 
and psychosocial factors.  
Type: Multi-faceted 
Description: Comprehensive inpatient programme including education, 
self-management, addressing socio-economic barriers via social worker and 
with additional follow up 
Setting: Inpatient, outpatient  
Provider(s): Asthma Clinical Nurse Specialist 
Format: Individual 
Structure: Number, frequency and duration of sessions not stated. Total 
duration of intervention dependent on length of stay (mean 2.1 days) with 
outpatient follow up 7 days after discharge 
Timing: Begun during admission for exacerbation 
Delivery methods/tools*: L, D, S, T (Total 4) 
Asthma content†: 10 topics related to asthma in general, management, 
medication, clinic attendance 
Other content: Other psychological issues, social or family issues, 
economic issues (screened for obstacles to care including inability to fill 
prescriptions, lack of transportation, lack of child care, substance abuse 
which addressed with social worker) 
Add-ons: Medical treatment (use of bedside spirometry, discharge 
planning and outpatient follow up which were not provided as part of usual 
care), Referral (liaison with social workers as needed) 
Usual care comprising 
inpatient treatment 
including nebulised 
albuterol and 
intravenous 
methylprednisolone 
sodium; education, 
peak flow measurement 
as needed. 
Groen & 
Pelser 
1960[33] 
The 
Netherlands 
Setting 
unclear 
Targetting: Definite 
Inclusion criteria: Appear to be adults 
(although not explicitly stated) hospitalised at 
least once for severe status asthmaticus, most 
Type: Psychosocial 
Description: Psychotherapy 
Setting: Not stated  
Provider(s): 2 Physicians with no specific training in psychiatry but 
1. Enhanced medical 
care comprising 
patients treated with 
symptomatic therapy 
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Study Country & 
setting 
Targetting of severe/difficult asthma and 
sample selection 
Intervention Control group(s) 
with many hospitalisations and very severe 
asthma.  
Exclusions: None stated. 
Rationale for targetting: No explicit 
discussion of at-risk status. 
experience with individual psycho-therapeutic techniques; support from 
Psychiatrist, Psychosomatic Researchers 
Format: Group (size not stated) 
Structure: Twice weekly sessions planned as 1 hour, actually up to 75 
mins, provided over several years 
Timing: No specific timing to asthma episode  
Delivery methods/tools*: D, R, FT (Total 3) 
Asthma content†: 1 topic related to medication 
Other content: Other psychological issues, social or family issues (little 
detail provided) 
Add-ons: None 
and, from 3 months to 4 
years, preventive 
therapy. 
2. Usual care 
comprising patients 
treated with 
symptomatic therapy 
only 
Kelso et 
al 
1995[34] 
USA 
Secondary 
care 
Targetting: Definite 
Inclusion criteria: African-Americans aged 
18+ years with a diagnosis of moderate-severe 
asthma (as per American Thoracic Society 
criteria) admitted to ED with acute asthma, 
who had 5+ ED visits in the last 2 years, 3+ 
ED visits in the last year, 2+ hospitalisations in 
the last 2 years OR an intensive care admission 
in the last 2 years. 
Exclusions: Patients with chronic bronchitis, 
emphysema, other chronic pulmonary disease, 
significant cardiac disease, psychosis or 
substance abuse, who were pregnant or unable 
to use a peak flow meter or metered dose 
inhaler with spacer correctly. 
Rationale for targetting: African-Americans 
have three times the mortality rate for asthma, 
similar to other ethnic minorities, and use the 
ED as their main source of care.  
Type: Multi-faceted 
Description: Education and long-term therapeutic intervention including 
education, self-management, medical treatment 
Setting: A&E, outpatient 
Provider(s): Study investigators 
Format: Individual 
Structure: 1 x 1-hour session during average 4.4- hour stay in ED with 
follow up at clinic after 1 week then every 2 weeks to 6 months for 1 year  
Timing: Immediately following emergency department treatment 
Delivery methods/tools*: L, D, S, T, W (Total 5) 
Asthma content†: 12 topics related to asthma in general, management, 
medication, triggers, clinic attendance 
Other content: Other health-related behaviours 
Add-ons: Medical treatment (prescriptions for inhaled steroids, beta-
agonists, emergency prednisolone and other medications as necessary). 
 
Usual care comprising 
patients meeting same 
inclusion criteria 
admitted or treated in 
ED during same time 
period as intervention 
group in other local 
hospitals. 
Kelso et 
al 
1996[35] 
USA 
Secondary 
care 
Targetting: Definite 
Inclusion criteria: African-Americans (but 
not explicitly stated in inclusion criteria) aged 
18+ years meeting US National Asthma 
Education & Prevention Programme criteria 
for moderate-severe asthma and with 5+ ED 
visits in last 2 years, 3+ ED visits in last year, 
2+ hospitalisations in last 2 years OR an 
intensive care admission in last 2 years. 
Type: Multi-faceted 
Description: Educational intervention with long-term management 
programme including education, self-management, medical treatment 
Setting: Outpatient  
Provider(s): Doctor, Pharmacist 
Format: Individual 
Structure: 1 x 1-hour initial visit followed by unstated number of follow 
up contacts provided monthly initially, then 2-3 monthly thereafter based 
on need (total intervention duration not stated) 
Usual care comprising 
retrospective group of 
patients, 14 out of 18 of 
whom saw primary care 
physician, 4 of whom 
saw a pulmonologist/ 
allergist. Frequency of 
office visits for control 
patients could not be 
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Study Country & 
setting 
Targetting of severe/difficult asthma and 
sample selection 
Intervention Control group(s) 
Exclusions: COPD; clinically significant 
cardiac disease; psychosis, substance abuse; 
pregnancy; inability to use peak flow meter or 
inhaler with spacer correctly. 
Rationale: Asthma morbidity and mortality 
higher in African-Americans. 
Timing: None 
Delivery methods/tools*: D, S, T, W (Total 4) 
Asthma content†: 14 topics related to asthma in general, management, 
medication, triggers, clinic attendance 
Other content: Attitudes/beliefs 
Add-ons: Medical treatment (optimisation of therapy and linking this to 
use of a self-management plan). 
determined.  
Mayo et 
al 
1990[36] 
USA 
Secondary 
care 
Targetting: Definite 
Inclusion criteria: Adults aged 18+ years with 
a primary diagnosis of acute asthma 
exacerbation as per American Thoracic Society 
definition and >4 ER visits in last 12 months or 
>1 hospitalisation in last 24 months. 
Exclusions: Mild asthma; remote residence or 
in prison, deaf mute; intravenous drug abusers; 
overt central nervous system/mental illness; 
severe alcoholism; private follow up; 
discharged before evaluation in hospital. 
Rationale for targetting: Local area (Lower 
East Side of New York) densely populated, 
socio-economically depressed, where asthma 
common cause for admission (670/year) and 
certain patients, labelled as “difficult”, have 
frequent admissions.  
Type: Multi-faceted 
Description: Specialist clinic programme comprising education, self-
management, open-door policy, medical treatment 
Setting: Outpatient  
Provider(s): 1 Respiratory Nurse Specialist, 1 Respiratory Doctor 
Format: Individual 
Structure: Initial session of >1 hour, followed by further >30 min sessions 
as needed, ranging from once a week to 1 every 6 months plus phone 
contact between for a maximum period of 8 months 
Timing: Patients recruited following admission, unclear how long after 
intervention began 
Delivery methods/tools*: D, S, T (Total 3) 
Asthma content†: 8 topics related to asthma in general, management, 
medication, clinic attendance 
Other content: None stated 
Add-ons: Medical treatment (reduction in or minimal use of medications 
required to control symptoms) 
Usual care comprising 
regular outpatient care 
in chest or medical 
clinic at local hospital, 
neighbourhood clinics 
or local physicians. 
Morice & 
Wrench 
2001[37] 
UK 
Secondary 
care 
Targetting: Likely 
Inclusion criteria: Patients aged 16-72 years 
hospitalised with a primary diagnosis of acute 
asthma. 
Exclusions: Unable or unwilling to complete 
follow up questionnaires; underlying COPD; 
previous participation in an educational 
programme from a hospital-based asthma 
nurse. 
Rationale for targetting: Inadequate self-
management contributes to mortality and 
morbidity. Written management plans are a 
postive step but their usefulness is dependent 
upon identifying and targetting those 
asthmatics most at risk. 
Type: Self-management 
Description: Education programme including self-management 
Setting: Inpatient  
Provider(s): 1 Asthma Nurse 
Format: Individual 
Structure: Minimum of 2 sessions, average 30 mins duration, delivered on 
consecutive days, plus one prior to discharge where possible, with total 
duration of intervention being 2+ days, dependent on length of admission 
Timing: Initial assessment within 48 hours of admission 
Delivery methods/tools*: L, D, S, W (Total 4) 
Asthma content†: 11 topics related to asthma in general, management, 
medication, triggers 
Other content: Other psychological issues (fears & anxieties related to 
home management), social or family issues (relatives involved at patient’s 
request), other  (influence of lifestyle activities e.g. leisure & occupation) 
Usual care comprising 
routine care from 
medical and nursing 
staff 
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Study Country & 
setting 
Targetting of severe/difficult asthma and 
sample selection 
Intervention Control group(s) 
Add-ons: None 
Nathell 
2005[38] 
Sweden 
Tertiary care 
 
Targetting: Likely 
Inclusion criteria: Adults born after 1941 (i.e. 
aged <55 years at time of identification) in a 
compulsory sick leave scheme primarily for 
manual workers who had been on sick leave 
from private sector work for more than 2 
weeks in 2 years due to respiratory symptoms 
and in whom a diagnosis of asthma was made 
as per American Thoracic Society criteria via 
interview and clinical examination. 
Exclusions: None stated. 
Rationale for targetting: Major proportion of 
the costs of asthma attributable to productivity 
losses and societal costs in relation to sick 
leave compensation, therefore important to 
reduce sick leave for asthma. 
Type: Multi-faceted 
Description: Rehabilitation programme comprising education, self-
management, optimization of medications, physical training, and coping 
skills acquisition 
Setting: Inpatient  
Provider(s): Physician, Nurse, Physiotherapist, Psychologist, Dietician, 
Vocational Therapist, Lab technician 
Format: Not stated 
Structure: 4 week programme (number, frequency & duration of contacts 
not stated) plus follow up by post/email/phone for one year 
Timing: No specific timing to asthma episode  
Delivery methods/tools*: L, D, S, T, W (Total 5) 
Asthma content†: 6 topics related to asthma in general, management, 
medication, triggers 
Other content: Other health-related behaviour (weight reduction or 
maintenance), Other psychological issues (coping with asthma, treatment 
and consequences) 
Add-ons: Medical care (optimisation of drug therapy), Exercise (personal 
physical training programme) 
Usual care in which 
patients advised to see 
their regular doctor as 
usual 
Osman et 
al 
2002[39] 
UK 
Secondary 
care 
Targetting: Likely 
Inclusion criteria: Patients aged 14-60 years 
with a confirmed diagnosis and hospitalised 
with acute asthma. 
Exclusions: None stated. 
Rationale for targetting: After acute asthma 
admissions there is a high rate of readmission 
with 1 in 5 patients being re-admitted. 
Type: Self-management 
Description: Self-management education programme  
Setting: Inpatient  
Provider(s): 1 Respiratory Nurse 
Format: Individual 
Structure: 2 x 30 min sessions (frequency and total intervention duration 
not stated) 
Timing: Following admission 
Delivery methods/tools*: D, S, W (Total 3) 
Asthma content†: 11 topics related to asthma in general, management, 
medication, triggers 
Other content: None stated 
Add-ons: None 
Usual care comprising 
standard care by more 
than 40 general medical 
and respiratory 
physicians, usually 
including follow up in 
an outpatient clinic at 
discretion of physician 
as per British Thoracic 
Society guidelines and 
local practice. Could 
include education or 
use of management 
plans. 
Put et al 
2003[40] 
Belgium 
Secondary 
care 
Targetting: Likely 
Inclusion criteria: Adults aged 18-65 years 
with a diagnosis of asthma according to 
American Thoracic Society criteria, and 
symptoms during the last 6 months (stated that 
Type: Psychosocial 
Description: Education and cognitive-behavioural intervention 
Setting: Outpatient  
Provider(s): 2 researchers 
Format: Individual 
Usual care comprising 
waiting list control 
group (no description 
given) 
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Study Country & 
setting 
Targetting of severe/difficult asthma and 
sample selection 
Intervention Control group(s) 
those reporting symptomology and impairment 
despite adequate medical treatment targetted 
but unclear from criteria how this was done). 
Exclusions: Occupational asthma, nicotine, 
drug or alcohol abuse, brittle asthma, previous 
participation in an educational or other asthma 
programme. 
Rationale for targetting: Patients reporting 
symptomology and impairment despite 
adequate medical treatment represent a 
challenge in clinical practice and cause 
frustration to clinicians 
Structure: 6 x 1-hour sessions (frequency and total intervention duration 
not stated) 
Timing: No specific timing to asthma episode 
Delivery methods/tools*: D, S, FT, W (Total 4) 
Asthma content†: 5 topics related to asthma in general, management, 
medication, triggers. 
Other content: Attitudes/beliefs (negative and irrational illness and 
medication perceptions and beliefs), Other psychological issues (problem 
areas as indicated e.g. anxiety) 
Add-ons: None 
 
Ross et al 
2005[41] 
Canada 
Research 
facility 
Targetting: Likely 
Inclusion criteria: Women (due to higher 
rates of panic disorder) aged 18-65 years with 
a physician diagnosis of asthma who had been 
referred to a pulmonary specialist or attended 
the ED for an acute asthma episode AND were 
identified as having a primary diagnosis of 
panic disorder (with no, mild or moderate 
agrophobic avoidance and at least 3 panic 
attacks in the last 3 weeks) following a DSM-
IV structured diagnotic interview and expert 
discussion. 
Exclusions: Recent change in psychotrophic 
medication or dose, other medical condition 
contraindicating participation (e.g. 
emphysema, organic brain syndrome), bipolar 
disorder, schizophrenia, obsessive-compulsive 
disorder, alcohol or drug dependence. 
Rationale for targetting: Higher than normal 
rates of panic disorder in asthma patients. 
Combination of panic and asthma attacks leads 
to mental, emotional and physical anguish, 
increased health service use and increased 
asthma morbidity and mortality. 
Type: Psychosocial 
Description: Cognitive-behavioural treatment and asthma education 
programme including self-managmenent 
Setting: Not stated 
Provider(s): 2 nurse clinicians (one trained in asthma, one in psychiatry) 
Format: Small group (<5 people) 
Structure: 12 x 90 min sessions, 8 conducted twice weekly for 4 weeks, 4 
conducted weekly for 4 weeks making 8 week intervention in total. 
Timing: No specific timing to asthma episode 
Delivery methods/tools*: L, D, S, FT, W (Total 5) 
Asthma content†: 10 topics related to asthma in general, management, 
medication, triggers 
Other content: Attitudes/beliefs (addressing faulty cognitive appraisals 
contributing to anxiety and panic), other psychological issues (general 
information on anxiety & panic, training in slow diaphragmatic breathing to 
reduce symptoms triggering panic attacks, addressing fear of bodily 
sensations associated with anxiety and panic) 
Add-ons: None 
 
Usual care comprising a 
waiting list (delayed 
treatment) control (no 
description given) 
Smith et 
al 
2005[42] 
UK 
Secondary 
care 
Targetting: Definite 
Inclusion criteria: Adults (attending adult 
clinic) with a confirmed diagnosis and severe 
Type: Multi-faceted 
Description: Psycho-educational programme comprising education, self-
management, psychological supervision and referral where indicated 
Usual care comprising 
routine asthma care 
provided by primary 
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Study Country & 
setting 
Targetting of severe/difficult asthma and 
sample selection 
Intervention Control group(s) 
asthma indicated by British Thoracic Society  
Step 4 or 5 treatment AND/OR one or more 
previous hospitalisations for asthma, who had 
failed to attend 2 or more routine asthma clinic 
appointments in close succession AND/OR 
were judged to be poorly adherent with other 
aspects of recommended management (e.g. 
poorly compliant with medication, not 
monitoring asthma as agreed). 
Exclusions: None stated. 
Rationale for targetting: Adverse 
psychosocial factors, including poor 
adherence, particularly in combination with 
severe asthma put patients at high risk of 
experiencing fatal and near-fatal attacks and 
hospitalisations for asthma. 
Setting: Home  
Provider(s): 1 Respiratory Nurse Specialist with supervision from a Health 
Psychologist & GP Liaison Psychiatrist  
Format: Individual 
Structure: 4 visits of around 1-hour provided fortnightly for 2 months with 
phone calls between visits followed by monthly phone calls for 4 months 
thereafter, making 6 month intervention in total  
Timing: No specific timing to asthma episode 
Delivery methods/tools*: D, S, P, G, R,  FT, T, W (Total 8) 
Asthma content†: 14 topics related to asthma in general, management, 
medication, triggers, clinic attendance 
Other content: Smoking, other health-related behaviours, attitudes/beliefs, 
other psychological issues, social or family issues, economic issues (topics 
and issues addressed according to individual needs) 
Add-ons: Medical treatment (liaison with medical services, additional 
testing and recommendations for adjustment of medication where 
necessary), Exercise (provision of programme as required on an individual 
basis), Referral (to medical, psychological and social services as necessary) 
and secondary health 
services according to 
local arrangements, 
generally comprising 
scheduled reviews at 
hospital and/or general 
practice-based asthma 
clinics every 3-6 
months, and use of 
emergency and 
inpatient services as 
needed.  
Yoon et 
al 
1993[43] 
Australia 
Secondary 
care 
 
Targetting: Likely 
Inclusion criteria: Patients aged 16-65 years 
with a diagnosis confirmed by history and 
reversibility of airflow obstruction who were 
hospitalised with a severe exacerbation, able to 
attend the education centre and literate in 
English. 
Exclusions: Signs of irreversible airways 
obstruction e.g. due to smoking; significant 
concurrent disease. 
Rationale for targetting: No explicit 
discussion of at-risk status.  
Type: Self-management 
Description: Education programme including self-management 
Setting: Outpatient  
Provider(s): Not stated  
Format: Medium group (5-15) 
Structure: 1 x 2.5-3 hour session 
Timing: Following hospital admission, no details on exact timing 
Delivery methods/tools*: L, D, S, W, V (Total 5) 
Asthma content†: 11 topics related to asthma in general, management, 
medication, triggers 
Other content: Social or family issues (encouraged to involve spouses or 
other key people) 
Add-ons: None 
Usual care comprising 
waiting list control with 
88% of all patients 
receiving specialist 
follow up care and most 
receiving some 
education including 
instruction in 
medication by clinical 
pharmacist before 
discharge, instruction in 
use of peak flow meter 
and chart for recording 
*Delivery methods/tools: L = Lecture/didactic teaching, D = Discussion, S = Skills training, P = Problem-solving, G = Goal-setting, R = Role play, FT = Formal therapeutic 
techniques (e.g. cognitive-behavioural therapy), T = Telephone, W = Written information, V = Video, A = Audio. 
†Asthma-specific topics assessed: Asthma general (e.g. causes, pathophysiology); Asthma management (symptom recognition, self-management principles, attack management, 
symptom monitoring, peak expiratory flow meter use/monitoring, action plan); Medications (general, inhaler use, compliance, side effects); Triggers (general, avoidance); clinic 
attendance. 
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Table 2 Methodological quality characteristics, follow ups reported, outcomes assessed and summary findings in individual studies  
 
Study Design Methodological details & quality assessment Follow-ups† Outcomes assessed‡ and summary findings 
  Randomisation/ 
selection of controls* 
Outcome 
assessment* 
Sample &  
attrition* 
Analysis & 
reporting* 
 
 (including relative risks (RR) and standardised mean 
differences (SMD), 95% confidence intervals where 
able to be calculated) 
Blixen et 
al 
2001[27] 
RCT A) Not stated 
B) No 
C) N/A 
D) Yes 
E) No 
F) Yes - 6 mths 
pre-specified 
G) 28 
H) Yes 
I) Yes 
J) 70% 
K) No 
L) Yes - minor differences 
M) 43% 
N) No 
O) Yes 
P) No 
Q) Yes 
ST (3 mths) 
MT (6 mths) 
Ad, A&E: comments on non-sig. ST and MT effects 
but no data presented 
Sym: not reported 
HS: SMDs (0.11, -0.74 to 0.97; 0.10, -0.99 to 1.19) 
calculated from mean overall asthma-specific quality of 
life scores suggest non-sig. ST and MT effects (p=0.8, 
p=0.86 respectively); no data presented from generic 
scale 
Psy: SMDs (-0.01, -0.86 to 0.85; 0.22, -0.87 to 1.32) 
calculated from mean depression scores suggest non-
sig. ST and MT effects (p=0.99, p=0.69 respectively) 
SA: comments on non-sig. ST and MT effects but no 
data presented  
SM: comments on non-sig. ST and MT effects across 
variety of areas related to adherence, use of action plan, 
monitoring, attendance but no data presented 
Brewin & 
Hughes 
1995[28] 
CPOS Concurrent comparison 
group selected from 
patients admitted to 
other hospitals in 
district 
D) Yes 
E) No 
F) Yes - one 
only 
G) 45 
H) Yes 
I) No 
J) 100% 
K) N/A  
L) No 
M) 70% 
N) No 
O) No 
P) No 
Q) No 
ST (3-5 mths) Sym: comments on non-sig. effects on scores from 
composite symptom measure presented in various ways 
(no p values reported)  
TL: non-sig. effects on % having time off (no p value 
reported) 
Kn: perceived knowledge scores sig. higher in control 
(p<0.000001) and actual knowledge scores sig. higher 
in intervention group (p=0.000029) 
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Study Design Methodological details & quality assessment Follow-ups† Outcomes assessed‡ and summary findings 
  Randomisation/ 
selection of controls* 
Outcome 
assessment* 
Sample &  
attrition* 
Analysis & 
reporting* 
 
 (including relative risks (RR) and standardised mean 
differences (SMD), 95% confidence intervals where 
able to be calculated) 
Castro et 
al 
2003[29] 
RCT A) Not stated 
B) Yes 
C) Sealed envelopes 
D) No 
E) Yes - 
admissions pre-
specified 
F) Yes - 12 mths 
pre-specified 
G) 96 
H) Yes 
I) No 
J) 100% 
K) N/A 
L) Yes - minor differences 
M) 69% 
N) No 
O) Yes 
P) Yes 
Q) Yes 
MT (6 mths) 
LT (12 mths) 
Ad: sig. LT effects on total numbers (p=0.04) and 
hospital days due to asthma (p=0.04), overall numbers 
(p=0.04) and hospital days from any cause (p=0.04), 
and on multiple readmissions (p=0.03) 
A&E: non-sig. LT effects on total numbers (p=0.52) 
HS: SMD (0.07, -0.41 to 0.55) calculated from mean 
overall asthma-specific quality of life scores suggests 
non-sig. MT effects (p=0.77); also reports non-sig. MT 
effects on mean subscale scores (all p>0.49) 
SA: non-sig. LT effects on total numbers of healthcare 
provider visits (p=0.82) 
Ford et al 
1997[30] 
RCT A) Not stated 
B) No 
C) N/A 
D) Yes 
E) Yes – A&E 
visits pre-
specified 
F) Yes – 12 
mths in results 
G) 163 
H) Yes 
I) Yes 
J) 42% 
K) Yes - similar  
L) Yes - similar 
M) 100% 
N) No 
O) Yes 
P) Yes 
Q) Yes 
ST (4 mths) 
MT (8 mths) 
LT (12 mths) 
Ad, OU, SA, Ex: Not reported for subgroup of interest 
A&E: sig. LT effects on monthly average attendance in 
total sample (p<0.0005) with no differential effect in the 
ethnic minority (p=0.6) subgroup of interest, but effects 
primarily seen during initial 4 months (p=0.003) rather 
than last 4 months (p=0.42) 
HS: sig. LT effects on monthly average number of 
limited activity days in total sample (p=0.04) with no 
differential effect in the ethnic minority (p=0.43) 
subgroup of interest, but effects primarily seen in initial 
4 months (p=0.03) rather than last 4 months (p=0.65) 
Kn, Bel: effects on overall sample not formally assessed 
but reported that no differential effects by race (p=0.51 
for interaction) 
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Study Design Methodological details & quality assessment Follow-ups† Outcomes assessed‡ and summary findings 
  Randomisation/ 
selection of controls* 
Outcome 
assessment* 
Sample &  
attrition* 
Analysis & 
reporting* 
 
 (including relative risks (RR) and standardised mean 
differences (SMD), 95% confidence intervals where 
able to be calculated) 
Garrett et 
al 
1994[31] 
RCT A) Not stated 
B) No 
C) N/A 
D) Yes 
E) No 
F) Yes - one 
only 
G) 500 
H) Yes 
I) Yes 
J) 51% 
K) Yes - non-participants 
younger, admission rates 
similar  
L) Yes - similar 
M) >90% 
N) Yes – similar 
O) Yes 
P) Yes - for 
some 
outcomes 
Q) No 
MT (9 mths) Ad: RR (0.79, 0.45 to 1.39, p=0.42) calculated from % 
of total sample admitted suggests non-sig. effects 
favouring intervention  
AE: RR (1.03, 0.80 to 1.32, p=0.83), calculated from % 
of total sample attending suggests non-sig. effects  
Sym: sig. effects on % total sample waking at night 
(p=0.02), coughing (p=0.05) and experiencing 
breathlessness (p=0.05); comments on non-sig. effects 
on other symptom measures but no data reported 
HS: comments on non-sig. effects but no data reported 
OU: RR (0.78, 0.53 to 1.14) calculated from  % adults 
attending for urgent GP care suggests non-sig. effects 
favouring intervention  
Psy: non-sig. effects on % adults with anxiety/panic at 
time of attack (p=0.25) 
Med: sig. effects on use of preventive medication in 
adults (p<0.0005) but data on this and other aspects of 
medication use not reported 
SA: comments on non-sig. effects but no data reported 
RF: non-sig. effects on % total sample in different 
categories of peak flow variability (p=0.08) 
Sev: sig. effects on % total sample reporting perceived 
improvement in severity (p=0.0005) 
TL: non-sig. effects on % total sample with days absent 
(p=0.3) 
SM: sig. effects on % adults with an action plan 
(p<0.01), having and using peak flow meter correctly 
(p<0.005) and adequately managing slow (p<0.005) and 
fast-onset (p<0.01) attacks; non-sig. effects on inhaler 
technique (p>0.01); comments on non-sig. effects on 
smoking and adherence but no data reported 
SS: sig. effects on % adults having someone to help 
with an asthma attacks (p<0.05) 
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Study Design Methodological details & quality assessment Follow-ups† Outcomes assessed‡ and summary findings 
  Randomisation/ 
selection of controls* 
Outcome 
assessment* 
Sample &  
attrition* 
Analysis & 
reporting* 
 
 (including relative risks (RR) and standardised mean 
differences (SMD), 95% confidence intervals where 
able to be calculated) 
George et 
al 
1999[32] 
RCT A) Random number 
table 
B) No 
C) N/A 
D) No 
E) No 
F) Yes - one 
only for main 
outcomes 
G) 77 
H) Yes 
I) No 
J) 88% 
K) No  
L) Yes - similar 
M) 65% 
N) No 
O) Yes 
P) Yes - f or 
some 
outcomes 
Q) No 
ST (1 mth) 
MT (6 mths) 
Ad: sig. MT effects on total number (p=0.04) but non-
sig. effects on mean length of stay (p=0.12)  
A&E: sig. MT effects on total number (p=0.04) 
SA: sig. ST effects on attendance at outpatient 
appointments (p=0.01) 
Groen & 
Pelser 
1960[33] 
CROS Retrospective 
identification of groups 
receiving different 
treatments at same 
centre 
D) No 
E) Yes - severity 
only 
F) Yes - one 
only 
G) 162 
H) Yes 
I) No  
J) 100% 
K) N/A 
L) Yes - age differences 
adjusted for 
M) 91% 
N) No 
O) Yes 
P) N/A 
Q) Yes 
LT (1+ yr) D: sig. effect on number dead (p=0.0004) but sig. lost 
when adjusted for age (p=0.14) 
Sev: sig. effect on number improved (p=0.0004), 
maintained after adjustment for age (p=0.00005) 
Kelso et 
al 
1995[34] 
CPOS Control group meeting 
same criteria and 
treated at same time, 
retrospectively 
identified from other 
hospitals in area 
serving similar 
population (low-
income, African-
Americans) 
D) No 
E) No 
F) Yes - one 
only 
G) 52 
H) Yes 
I) No 
J) Not stated 
K) No  
L) Yes - differences in age 
& adult-onset asthma 
adjusted for 
M) Not stated 
N) No 
O) No 
P) No - but 
actually done 
Q) Yes 
LT (12 mths) Ad: non-sig. effects on average number of admissions 
(p=0.37) 
A&E: sig. effects on average number of attendances 
(p<0.01) 
Med, SM, Kn: reported for intervention group only 
Kelso et 
al 
1996[35] 
CPOS Control group 
retrospectively 
identified via chart 
review 
D) No 
E) No 
F) No 
G) 39 
H) Yes 
I) No 
J) Not stated 
K) No  
L) Yes - similar 
M) Not stated 
N) No 
O) Yes 
P) No 
Q) Yes 
LT (1 yr & 2 
yrs) 
Ad: sig. effects on mean number of admissions (p<0.05 
at 1 and 2 years) 
A&E: sig. effects on mean number of attendances 
(p<0.05 at 1 and 2 years) 
HS, Med, Kn: reported for intervention group only 
Sym: No outcome data reported 
D: 1 in intervention group 
ITU: 1 in intervention (later died), 2 in control group 
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Study Design Methodological details & quality assessment Follow-ups† Outcomes assessed‡ and summary findings 
  Randomisation/ 
selection of controls* 
Outcome 
assessment* 
Sample &  
attrition* 
Analysis & 
reporting* 
 
 (including relative risks (RR) and standardised mean 
differences (SMD), 95% confidence intervals where 
able to be calculated) 
Mayo et 
al 
1990[36] 
RCT A) Patient record 
number 
B) No 
C) N/A 
D) No 
E) Yes - 
admissions in 
results 
F) Yes - one 
only 
G) 104 
H) Yes 
I) No 
J) 100% 
K) N/A  
L) Yes - similar 
M) 100% 
N) No 
O) Yes 
P) No - but 
actually done 
Q) No 
MT (max. 8 
mths) 
Ad: sig. effects on number (p<0.004) and days per 
patient (p<0.02) 
Med: reported for intervention group only 
D: 1 death in control group 
Morice & 
Wrench 
2001[37] 
RCT A) Not stated 
B) No 
C) N/A 
D) No 
E) No 
F) No 
G) 80 
H) Yes 
I) No 
J) Not stated 
K) No  
L) Yes - minor differences 
M) 75% 
N) No 
O) Yes 
P) No - but 
actually done 
for some 
outcomes 
Q) No 
ST (6 wks) 
MT (6 mths) 
LT (18 mths) 
Ad: RR (0.91, 0.44 to 1.90, p=0.80) calculated from 
number of patients admitted suggested non-sig. LT 
effects favouring intervention 
A&E: RR (5.00, 0.25 to 100.97, p=0.29) calculated 
from number of patients attending suggests non-sig. LT 
effects favouring control 
OU: RR (0.93, 0.50 to 1.72) calculated from number of 
patients having urgent GP visits/call-outs suggests non-
sig. MT effects favouring intervention  
Med: sig. MT effects on beta-agonist use (p<0.01) 
(selective reporting) 
SM: sig. ST and MT effects on % with written 
management plan (p<0.001, p<0.001), sig. ST effects on 
use of peak flow meter (p<0.005) and knowledge of 
peak flow (p<0.01), sig. MT effects on % performing 
various appropriate actions (p<0.01) (but data on these 
not formally reported) 
Nathell 
2005[38] 
RCT A) Computerised list 
B) Yes 
C) Conducted by 
independent researcher 
D) No 
E) Yes – sick 
leave pre-
specified 
F) No 
G) 197 
H) Yes 
I) No 
J) 83% 
K) Yes - similar  
L) Yes - similar  
M) 89% 
N) No 
O) Yes 
P) Yes 
Q) Yes 
LT (1, 2 & 3 
yrs) 
TL: non-sig. effects  on  overall median sick leave days 
at 1 (p=0.47), 2 (p=0.18) and 3 years (p=0.12), but sig. 
effects at 3 years on subgroup with previous physician 
diagnosis of asthma and non-smokers (both p=0.02) 
Med: sig. effects on % using of inhaled steroids at 1 
(p=0.03) but not 2 (p=0.13) or 3 years (p=0.88) 
SM: non-sig. effects on % smoking at 1 (p=0.45), 2 
(p=0.87) or 3 years (p=0.88) 
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Study Design Methodological details & quality assessment Follow-ups† Outcomes assessed‡ and summary findings 
  Randomisation/ 
selection of controls* 
Outcome 
assessment* 
Sample &  
attrition* 
Analysis & 
reporting* 
 
 (including relative risks (RR) and standardised mean 
differences (SMD), 95% confidence intervals where 
able to be calculated) 
Osman et 
al 
2002[39] 
RCT A) Random number 
table 
B) Yes 
C) Serially numbered 
envelopes 
D) Yes 
E) Yes - 
admissions pre-
specified 
F) Yes – 12 
mths pre-
specified 
G) 280 
H) Yes 
I) Yes 
J) 60% 
K) No  
L) Yes - differences in 
gender adjusted for 
M) 95% 
N) No 
O) Yes 
P) No 
Q) Yes 
ST (1 mth) 
LT (12 mths) 
Ad: RRs calculated from number of patients admitted 
suggests non-sig. ST effect favouring intervention (0.27, 
0.03 to 2.41, p=0.24), sig. LT effect favouring 
intervention (0.62, 0.39 to 0.99, p=0.04) which non-sig. 
when analysis confined to subgroup with previous 
admissions (0.88, 0.54 to 1.44, p=0.62) 
Sym: sig. ST effects on % experiencing day and night-
time symptoms (both p=0.01), non-sig. effects on % 
experiencing restrictions to activity (p=0.12), but non-
sig. effects when analysis confined to subgroup with 
previous admissions (p=0.70, 0.33, 0.17 respectively) 
Sat: sig. ST effects on % in total sample and subgroup 
with previous admissions satisfied with care (p<0.001) 
Put et al 
2003[40] 
RCT A) Drawing envelope 
B) Yes 
C)  Sealed, non-
transparent envelopes 
D) Yes 
E) No 
F) No 
G) 25 
H) No 
I) No 
J) 51% 
K) No  
L) Yes – controls prescribed 
more anticholinergics, 
otherwise similar 
M) 39% 
N) No 
O) Yes 
P) No 
Q) Yes 
ST (1. post-
treatment 
(actual 
timepoint not 
stated) for 
intervention & 
3 mths for 
control. 2. 3 
mths for 
intervention & 
6 mths for 
control) 
Sym: sig. effects on mean obstruction (p=0.04), fatigue 
(p=0.001) and irritation (p=0.03) but not dyspnoea, 
hyperventilation or anxiety subscale scores (p values for 
latter not reported) 
RF: sig. effects on mean day (p=0.03) and night-time 
(p=0.04) peak flow rates 
HS: SMD (1.18, 0.28 to 2.08) calculated from mean 
overall asthma-specific quality of life scores suggests 
sig. effect (p=0.01); also reports sig. effects on mean 
activity limitation (p<0.0001), symptom (p<0.0001) and 
emotion (p=0.003) (p<0.0001), but not environment 
subscale scores (p value not reported) 
Psy: SMD (-1.23, -2.14 to -0.32) calculated from mean 
negative emotionality scores suggests sig. effect 
(p=0.008) 
SM: sig. effects on mean adherence scores (p=0.002) 
SE, Bel, Kn: sig. effects on mean self-efficacy 
(p=0.008), attitude (p<0.0001) and knowledge 
(p<0.0001) subscale scores of asthma-specific 
questionnaire 
 52
Study Design Methodological details & quality assessment Follow-ups† Outcomes assessed‡ and summary findings 
  Randomisation/ 
selection of controls* 
Outcome 
assessment* 
Sample &  
attrition* 
Analysis & 
reporting* 
 
 (including relative risks (RR) and standardised mean 
differences (SMD), 95% confidence intervals where 
able to be calculated) 
Ross et al 
2005[41] 
RCT A) Not stated 
B) No 
C) N/A 
D) No 
E) No 
F) No 
G) 34 
H) Yes 
I) No 
J) 71% 
K) Yes - similar  
L) Yes – intervention group 
more severe asthma, 
otherwise similar 
M) 74% 
N) Yes – similar 
O) Yes 
P) No 
Q) Yes 
ST (8 wks), 
MT (6 mths 
for 
intervention 
only) 
Psy: SMD (-0.52, -1.36 to 0.32) calculated from mean 
depressive symptoms scores suggests non-sig. effect 
favouring intervention (p=0.23); also reports sig. ST 
effects on total number of panic attacks (p=0.03), mean 
total scores on scales assessing intensity of anxiety 
symptoms (p<0.01) and fear of anxiety-related bodily 
sensations (p<0.01) which remained apparent to 6 
months, but non-sig. ST effects on mean scores of 
agrophobic avoidance (p=0.2) 
RF: sig. ST effects on mean morning peak flow rate 
(p<0.05) but non-sig. effects on peak flow variability 
(p=0.14)  
Sym: SMD (-0.19, -1.07 to 0.69) calculated from mean 
days with symptoms suggests non-sig. ST effect 
favouring intervention (p=0.68). 
HS: SMD (0.67, -0.18 to 1.53) calculated from mean 
overall asthma-specific quality of life scores suggests 
non-sig. ST effect favouring intervention (p=0.12). 
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Study Design Methodological details & quality assessment Follow-ups† Outcomes assessed‡ and summary findings 
  Randomisation/ 
selection of controls* 
Outcome 
assessment* 
Sample &  
attrition* 
Analysis & 
reporting* 
 
 (including relative risks (RR) and standardised mean 
differences (SMD), 95% confidence intervals where 
able to be calculated) 
Smith et 
al 
2005[42] 
RCT A) Computer generated 
list 
B) No 
C) N/A 
D) No 
E) Yes - 
symptoms pre-
specified 
F) Yes – 6 mths 
pre-specified 
G) 92 
H) Yes 
I) Yes 
J) 51% 
K) Yes - non-participants 
more likely male and non-
attenders at clinic  
L) Yes - differences in 
gender & education adjusted 
for 
M) 83% 
N) Yes – similar 
O) Yes 
P) Yes 
Q) Yes 
ST (2 mths) 
MT (6 mths) 
LT (12 mths) 
Ad: RRs calculated from number of patients admitted 
suggests non-sig. MT (1.55, 0.72 to 3.32, p=0.26) and 
LT effects (1.26, 0.67 to 2.37, p=0.48) favouring control 
(additional data provided by authors) 
A&E: RRs calculated from number of patients 
attending suggests non-sig. MT (1.59, 0.64 to 3.95, 
p=0.32) and LT effects (1.16, 0.65 to 2.15, p=0.62) 
favouring control (additional data provided by authors) 
Med: sig. ST effects on beta-agonist use (p=0.04), not 
maintained in MT (p=0.2) 
Sym: SMD calculated from mean scores on composite 
symptom scale suggest non-sig. ST effects favouring 
intervention (-0.22, -0.65 to 0.21, p=0.31) and non-sig. 
MT (0.06, -0.36 to 0.49, p=0.77) and LT effects (-0.04, 
-0.46 to 0.39, p=0.87). 
HS: sig. ST (p=0.01), MT (p=0.01) and LT effects 
(p=0.03) on mean asthma-specific quality of life scores 
seen only from fully adjusted analyses, otherwise non-
sig. effects (all p>0.56); non-sig. ST (p=0.78, p=0.60), 
MT (p=0.67, p=0.94) and LT effects (p=0.80, p=0.56) 
respectively on mean physical function and mental 
health subscale scores from generic questionnaire  
Psy: SMDs (0.10, -0.33 to 0.53; 0.27, -0.16 to 0.70; 
0.02, -0.41 to 0.44) calculated from mean depression 
scores suggest non-sig. ST, MT and LT effects (p=0.66; 
p=0.22; p=0.94 respectively); also reports no clear 
effects on mean anxiety or general psychological 
morbidity scores, formal analyses not undertaken 
SM : no clear ST, MT or LT effects on mean adherence 
scores, % smoking or identifying additional triggers, 
formal analyses not undertaken 
SE: no clear ST, MT or LT effects on mean perceived 
control of asthma scores, formal analyses not 
undertaken 
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Study Design Methodological details & quality assessment Follow-ups† Outcomes assessed‡ and summary findings 
  Randomisation/ 
selection of controls* 
Outcome 
assessment* 
Sample &  
attrition* 
Analysis & 
reporting* 
 
 (including relative risks (RR) and standardised mean 
differences (SMD), 95% confidence intervals where 
able to be calculated) 
Yoon et 
al 
1993[43] 
RCT A) Not stated 
B) No 
C) N/A 
D) Yes 
E) No 
F) Yes - 10 
months in 
results 
G) 76 
H) Yes 
I) No 
J) 41% 
K) Yes - women, non-
smokers, those with 
physician more likely to 
participate  
L) Yes - similar 
M) 74% 
N) No 
O) Yes 
P) No 
Q) Yes 
ST (5 mths) 
MT (10 mths) 
Ad: RR (0.15, 0.02 to 1.17, p=0.07) calculated from 
number of patients admitted suggests non-sig. MT 
effect favouring intervention 
A&E: RR (0.45, 0.13 to 1.62, p=0.22) calculated from 
number of patients admitted suggests non-sig. MT 
effects favouring intervention  
RF: sig. effects on prevention of declines in mean FEV1 
and FVC in ST (p=0.01, p<0.05 respectively) but not 
MT (no p values reported); comments on little effect on 
mean peak flow variability (no p values reported) 
Sev: non-sig. MT effects on mean perceived severity 
scores (p=0.85) 
Sym: SMD (-0.10, -0.62 to 0.42, p=0.71) calculated 
from mean scores on composite symptom scale suggest 
non-sig. MT effects favouring intervention 
TL: non-sig. MT effects on % absent for >2 weeks (p 
value not reported) 
Psy: SMD (0.01, -0.51 to 0.53) calculated from mean 
scores for psychosocial disturbance due to asthma 
suggests non-sig. MT effects (p=0.97)  
SM: sig. MT effects on mean scores for use of an action 
plan (p<0.001) and differentiation of mild from severe 
attacks (p=0.005) 
Kn: sig. MT effects on mean scores for knowledge of 
asthma (p<0.07) and medications (p<0.05) 
Bel: sig. MT effects on mean scores for appropriate 
health beliefs (p<0.001) 
*Methodological details and quality criteria assessed: A) Randomisation method, B) Concealed allocation?, C) Concealment method, D) Blinded outcome assessment? E) Single primary outcome specified/reported? F) 
Single primary endpoint specified? G) Total sample size, H) Clear selection criteria?, I) Power calculation?, J) Participation rate, K) Comparability of non-participants checked?, L) Baseline comparability of groups checked?, 
M) Minimum follow-up, N) Comparability of withdrawals checked? O) Provided details of analysis? P) Specified ITT analysis? Q) Adequate outcome reporting (numerator and denominator for binary outcomes, point estimates 
plus measures of variability for continuous data)? 
†Follow-up: This was standardised, as far as possible, to represent follow up from the start of the intervention or baseline assessment (assumed to be close together) and taken as the average duration or mid-point of a range 
where length of follow up varied across individual patients within studies, and was categorised into short-term (ST) = 0 to <6 months; medium-term (MT) = 6 to <12 months; and long-term (LT) = 12+ months 
‡Outcome categories: Ad = hospital admissions/re-admissions, A&E = A&E/ED attendances, OU = Other unscheduled healthcare attendances, SA = scheduled healthcare attendances, Med = medication use, Ex = 
exacerbations, TL = time lost from work, Sym = symptoms/asthma control, Sev = severity, RF = respiratory function, HS = health status/quality of life, Psy = psychological morbidity, SM = self-management behaviour, SE = 
self-efficacy/perceived control, Bel = beliefs/attitudes, Kn = knowledge, SS = social support 
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Table 3 Numbers of studies assessing and reporting adequate data for different categories of outcomes and syntheses of findings from these in 
short- (ST), medium- (MT) and long-term (LT) (where 0 = non-significant effects; + = significant effects of psycho-educational intervention 
compared to usual care) 
 
Type of outcome Number of 
studies 
reporting 
assessment of 
outcome 
Number of studies 
not reporting 
comparative 
numerical data for 
outcome 
Number of and findings from 
studies reporting adequate 
comparative numerical 
outcome data from which 
meaningful summary statistics 
for meta-analysis could not be 
calculated 
Number of and 
findings from RCTs 
reporting data 
suitable for 
inclusion in meta-
analyses 
Summary findings, including pooled estimates 
(RR/SMD, 95% confidence intervals) from meta-
analyses and any subgroup and sensitivity 
analyses where able to be undertaken 
 COSs RCTs COSs RCTs COSs RCTs RCTs  
Admission/re-
admission 
2 10 0 2[27,30] 2 
 
 
 
 
LT:  
0,+[34,35] 
3 
 
 
MT:  
+,+[32,36] 
LT:  
+[29] 
5 
ST:  
0[39] 
MT:  
0,0,0[31,42,43] 
LT:  
0,0,+[37,42,39] 
ST: Only one study examining effects.  
MT: 5 individual studies show conflicting findings, 
pooled estimate across 3 studies (RR=0.83, 0.35 to 
1.94) suggests a small and non-sig. effect (p=0.67).  
LT: 6 individual studies show conflicting findings 
with only clearly sig. effects from an RCT confined 
to single study of a multi-faceted intervention. 
Pooled estimate across 3 studies (RR=0.85, 0.55 to 
1.32,) suggests a small and non-sig. effect (p=0.47), 
which eliminated when data from a higher risk 
subgroup in one study were used in analysis 
(RR=0.99, 0.70 to 1.39, p=0.94).  
Overall (min. follow up = 6 months): 10 individual 
studies show conflicting findings. Pooled estimate 
across 5 studies (RR=0.79, 0.55 to 1.14) suggests a 
small and non-sig. effect (p=0.21) (Figure 2). 
However this was of borderline significance when a 
fixed effects model (RR=0.75, 0.56 to 0.99, p=0.04) 
or odds-ratio statistic was used (OR=0.70, 0.49 to 
0.99, p=0.04). Pooled estimate (RR=0.70, 0.50 to 
0.97) from subgroup analysis in which 4 studies with 
likely targetting were considered separately from 
only study with definite targetting showed sig. effect 
(p=0.03). Subgroup analysis of higher risk patients in 
one individual study and this sensitivity analysis 
suggest that any positive effects on admissions in 
those with severe asthma may not extend to patients 
with multiple risk factors. 
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Type of outcome Number of 
studies 
reporting 
assessment of 
outcome 
Number of studies 
not reporting 
comparative 
numerical data for 
outcome 
Number of and findings from 
studies reporting adequate 
comparative numerical 
outcome data from which 
meaningful summary statistics 
for meta-analysis could not be 
calculated 
Number of and 
findings from RCTs 
reporting data 
suitable for 
inclusion in meta-
analyses 
Summary findings, including pooled estimates 
(RR/SMD, 95% confidence intervals) from meta-
analyses and any subgroup and sensitivity 
analyses where able to be undertaken 
 COSs RCTs COSs RCTs COSs RCTs RCTs  
A&E/ED 
attendance 
2 8 0 1[27] 2 
 
 
LT: 
+,+[34,35] 
3 
MT: 
+[32] 
LT:  
0,+[29,30] 
4 
MT:  
0,0,0[31,42,43] 
LT: 
0,0[37,42] 
ST: No data.  
MT: Data from 4 individual studies and pooled 
estimate across 3 studies (RR=1.03, CI=0.69-1.51, 
p=0.9) suggest a lack of positive effects.  
LT: 6 individual studies show conflicting findings, 
pooled estimate across 2 studies (RR=1.22, 0.69 to 
2.15) suggests a small and non-sig. effect (p=0.50) 
favouring usual care. 
Overall (min. follow up = 6 months): 9 individual 
studies show conflicting findings, pooled estimate 
across 4 studies (RR=1.03, 0.82 to 1.29) suggests no 
overall effect (p=0.8) which was not greatly altered 
by using a fixed effects method, odds-ratio statistic 
or a subgroup analysis in the 3 studies with likely 
targetting. 
Symptoms/asthma 
control 
2 7 1[35]] 1[27] 1 
ST:  
0[28] 
3 
ST:  
+,+ (0 for higher 
risk 
subgroup[40,39] 
MT:  
+[31] 
 
3 
ST:  
0,0[41,42] 
 
 
MT: 
0,0[42,43] 
LT:  
0[42] 
ST: 5 individual studies show conflicting findings. 
Pooled estimate across 2 studies reporting composite 
symptom scores (SMD=-0.22, -0.60 to 0.17) suggests 
a small and non-sig. effect (p=0.27). 
MT: 3 individual studies show conflicting findings. 
Pooled estimate across 2 studies reporting composite 
symptom scores (SMD=0.00, -0.33 to 0.33) suggests 
no overall effect (p=0.99). 
LT: Only one study examining effects. 
Overall (min. follow up = 1 month): 7 individual 
studies show conflicting findings. Pooled estimate 
across 3 studies reporting composite symptom scores 
(SMD=-0.08, -0.39 to 0.23) suggests a small and 
non-sig. effect (p=0.63) which not altered by use of a 
fixed effects model. Subgroup analysis of higher risk 
patients in one individual study suggests that any 
positive effects on symptoms in those with severe 
asthma may not extend to patients at higher risk. 
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Type of outcome Number of 
studies 
reporting 
assessment of 
outcome 
Number of studies 
not reporting 
comparative 
numerical data for 
outcome 
Number of and findings from 
studies reporting adequate 
comparative numerical 
outcome data from which 
meaningful summary statistics 
for meta-analysis could not be 
calculated 
Number of and 
findings from RCTs 
reporting data 
suitable for 
inclusion in meta-
analyses 
Summary findings, including pooled estimates 
(RR/SMD, 95% confidence intervals) from meta-
analyses and any subgroup and sensitivity 
analyses where able to be undertaken 
 COSs RCTs COSs RCTs COSs RCTs RCTs  
Health 
status/quality of 
life 
1 7 1[35] 1[31] 0 2 
ST:  
0[42]  
MT:  
0[42] 
LT:  
0,+[42,30] 
4 
ST:  
0,0,+[27,41,40] 
MT:  
0,0[27,29] 
 
ST: 4 individual studies mainly show a lack of 
positive effects, pooled estimate across 3 studies 
reporting overall scores on asthma-specific quality of 
life scale (SMD=0.64, 0.05 to 1.24,) suggests a sig. 
effect (p=0.03). 
MT: 3 individual studies show a lack of positive 
effects, pooled estimate across 2 studies reporting 
overall scores on asthma-specific quality of life scale 
(SMD=0.08, -0.37 to 0.52) suggests a small and non-
sig. effect (p=0.74). 
LT: 2 individual studies show conflicting findings. 
Overall (min. follow up = 8 wks): 6 individual 
studies show mainly non-sig. effects, with clear 
positive effects seen only in studies of 2 psychosocial 
interventions in short-term. Pooled estimate across 4 
studies reporting overall scores on asthma-specific 
quality of life scale (SMD=0.45, -0.07 to 0.98) 
suggests a small and non-sig. effect (p=0.09) (Figure 
3), which was of borderline sig. when a fixed effects 
model was used (SMD=0.36, 0.00 to 0.72, p=0.05). 
When studies were divided into subgroups according 
to their degree of targetting, sig. pooled effects across 
the 2 with likely targetting (SMD=0.91, 0.29 to 1.53, 
p=0.004) did not extend to the 2 with definite 
targetting (SMD=0.08, -0.37 to 0.52, p=0.74). 
Psychological 
morbidity 
0 6 0 0 0 1 
 
 
MT: 
0[31] 
 
5 
ST:  
0,0,+,+[27,42,40,41] 
MT:  
0,0,+[27,42,43] 
LT:  
0[42] 
ST: 4 individual studies show conflicting findings, 
pooled estimate across 4 studies reporting scores of 
negative mood (SMD=-0.34, -0.92 to 0.24) suggests 
a small and non-sig. effect (p=0.25). 
MT: 4 individual studies mainly suggest a lack of 
positive effects, pooled estimate across 3 studies 
reporting scores of negative mood (SMD=0.17, -0.15 
to 0.49) suggests a small and non-sig. effect (p=0.30) 
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Type of outcome Number of 
studies 
reporting 
assessment of 
outcome 
Number of studies 
not reporting 
comparative 
numerical data for 
outcome 
Number of and findings from 
studies reporting adequate 
comparative numerical 
outcome data from which 
meaningful summary statistics 
for meta-analysis could not be 
calculated 
Number of and 
findings from RCTs 
reporting data 
suitable for 
inclusion in meta-
analyses 
Summary findings, including pooled estimates 
(RR/SMD, 95% confidence intervals) from meta-
analyses and any subgroup and sensitivity 
analyses where able to be undertaken 
 COSs RCTs COSs RCTs COSs RCTs RCTs  
favouring usual care. 
LT:  Only one study examining effects. 
Overall (min. follow-up = 8 wks): 6 individual 
studies mainly suggest a lack of positive effects with 
clear effects primarily confined to studies of 
psychosocial interventions in the short-term. Pooled 
estimate across 5 studies reporting scores for various 
negative mood states (SMD=-0.23, -0.66 to 0.19) 
suggests a small and non-sig. effect (p=0.28) (Figure 
4), which not greatly altered by use of a fixed effects 
model. When studies were divided into subgroups 
according to their degree of targetting, small but non-
sig. pooled effects across the 2 with likely targetting 
(SMD=-0.51, -1.23 to 0.22, p=0.17) did not extend to 
the 2 with definite targetting (SMD=0.04, -0.36 to 
0.44, p=0.83). 
Self-management 
behaviour 
1 7 1[34] 1[27] 0 6 
ST:  
+,+,+[37,40,42] 
MT:  
0,+,+,+[42,31,37
,43] 
LT:  
0,0[38,42] 
N/A 
No summary 
statistics calculated 
as different aspects 
assessed and reported 
in different ways 
Overall (min. follow up = 3 mths): 6 individual 
studies showed mainly positive ST and MT effects 
with respect to various aspects of self-management 
including use of action plans, use of peak flow 
meters, recognition and management of attacks. 
However, 2 studies suggest these may not be 
maintained in the longer-term and several that effects 
may not extend to other aspects of self-management 
(e.g. smoking). 
Medication use 2 5 2[34][35] 2[31] 
[36] 
0 3 
ST:  
+[42] 
MT: 
0,+ 
[42,37] 
LT:  
0,+ 
N/A 
No summary 
statistics calculated 
as different aspects 
assessed and reported 
in different ways 
Overall (min. follow up = 6 mths): 3 individual 
studies showed mainly positive effects, 2 with 
respect to reductions in beta-agonist use and 1 with 
respect to proportions using preventive medication, 
although in one effects were confined to the short-
term. 
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Type of outcome Number of 
studies 
reporting 
assessment of 
outcome 
Number of studies 
not reporting 
comparative 
numerical data for 
outcome 
Number of and findings from 
studies reporting adequate 
comparative numerical 
outcome data from which 
meaningful summary statistics 
for meta-analysis could not be 
calculated 
Number of and 
findings from RCTs 
reporting data 
suitable for 
inclusion in meta-
analyses 
Summary findings, including pooled estimates 
(RR/SMD, 95% confidence intervals) from meta-
analyses and any subgroup and sensitivity 
analyses where able to be undertaken 
 COSs RCTs COSs RCTs COSs RCTs RCTs  
[42,38] 
Knowledge 3 4 2[34][35] 1[30] 1 
ST:  
+[28] 
2 
ST:  
+[40] 
MT:  
+[43] 
N/A 
No summary 
statistics calculated 
as different aspects 
assessed and reported 
in different ways 
Overall (min. follow up = 3 mths): 3 individual 
studies, 2 of self-management and 1 of a 
psychosocial intervention, all showed positive effects 
on various combined measures of knowledge in 
relation to asthma, medications and self-
management. 
Scheduled health 
care attendances 
0 5 0 3[27,30,
31] 
0 1 
ST: 
+[32] 
LT:  
0[29] 
N/A 
No summary 
statistics calculated 
as both reported in 
different ways  
Overall (min. follow up = 1 mth): 2 individual 
studies showed conflicting findings, with clear 
positive effects seen only in the short-term following 
a multi-faceted intervention.  
Respiratory 
function 
0 4 0 0 0 4 
ST: 
+,+,+ 
[40,41,43] 
MT:  
0,0[31,43] 
N/A 
No summary 
statistics calculated 
as different aspects 
assessed and reported 
in different ways 
Overall (min. follow up = 8 wks): 3 individual 
studies showed mainly positive ST effects, 2 of 
psychosocial interventions with respect to peak flow 
rates, and 1 of a self-management intervention with 
respect to FEV1 and FVC, but data from 2 studies 
suggest these may not be maintained in the medium-
term. 
Time lost from 
work 
1 3 0 0 1 
ST:  
0[28] 
3 
 
 
MT:  
0,0[31,43] 
LT:  
0 (+ in lower 
risk 
subgroup)[38] 
N/A 
No summary 
statistics calculated 
as all reported in 
different ways 
Overall (min. follow up = 3 mths): 4 individual 
studies showed non-sig. effects, except when long-
term analysis in one study was confined to a lower 
risk group of non-smokers. 
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Figure 2 Forest plot showing meta-analysis, divided by asthma subgroups (likely and definite targetting), of relative risks ratios (RR) 
calculated from proportions of adults admitted for asthma at latest follow up reported by studies 
 
 61
Figure 3 Forest plot showing meta-analysis, divided by asthma subgroups (likely and definite targetting), of standardised mean differences 
(SMD) calculated from asthma-specific quality of life scores (where higher scores = better quality of life) at latest follow up reported by 
studies 
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Figure 4 Forest plot showing meta-analysis, divided by asthma subgroups (likely and definite targetting), of standardised mean differences 
(SMD) calculated from psychological morbidity scores (where higher scores = greater morbidity) at latest follow up reported by studies 
 
 
 
